Category	Term	Count	%	PValue	Genes	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
UP_KEYWORDS	Ubl conjugation	25	43.103448275862064	4.78636401302613E-12	57379, 988, 81620, 672, 79577, 6310, 1111, 100526767, 9255, 867, 9575, 9738, 846, 23624, 57805, 948, 7965, 1050, 6045, 8314, 468, 367, 80184, 23607, 22809	58	1705	20581	5.203003337041157	7.371045995796521E-10	7.371045995796521E-10	5.7417626209144146E-9

ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
79058, 79058, 79058, 79058, 79058, 79058, 79058, 79058, 79058	ASPSCR1, UBX domain containing tether for SLC2A4(ASPSCR1)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0042593~glucose homeostasis,GO:0046324~regulation of glucose import,	GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0019898~extrinsic component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,	IPR001012:UBX,IPR021569:GLUT4 regulating protein TUG,	hsa05202:Transcriptional misregulation in cancer,	606243~Alveolar soft-part sarcoma,			Acetylation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Tether containing UBX domain for GLUT4,domain:UBX,modified residue,region of interest:Interaction with GLUT4,sequence conflict,sequence variant,site:Breakpoint for translocation to form ASPSCR1-TFE3,splice variant,
215, 215, 215, 215	ATP binding cassette subfamily D member 1(ABCD1)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0007031~peroxisome organization,GO:0015910~peroxisomal long-chain fatty acid import,GO:0015919~peroxisomal membrane transport,GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase,GO:0036109~alpha-linolenic acid metabolic process,GO:0042758~long-chain fatty acid catabolic process,GO:0042760~very long-chain fatty acid catabolic process,GO:0043651~linoleic acid metabolic process,GO:0055085~transmembrane transport,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005779~integral component of peroxisomal membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005215~transporter activity,GO:0005324~long-chain fatty acid transporter activity,GO:0005325~peroxisomal fatty-acyl-CoA transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019899~enzyme binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005283:Peroxysomal long chain fatty acyl transporter,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,	300100~Adrenoleukodystrophy,300100~Adrenomyeloneuropathy, adult,		SM00382:AAA,	ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 1,domain:ABC transmembrane type-1,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PEX19,sequence conflict,sequence variant,transmembrane region,
5825	ATP binding cassette subfamily D member 3(ABCD3)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,		GO:0006633~fatty acid biosynthetic process,GO:0006635~fatty acid beta-oxidation,GO:0007031~peroxisome organization,GO:0014070~response to organic cyclic compound,GO:0015910~peroxisomal long-chain fatty acid import,GO:0042493~response to drug,GO:0042760~very long-chain fatty acid catabolic process,GO:0055085~transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005324~long-chain fatty acid transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR005283:Peroxysomal long chain fatty acyl transporter,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04146:Peroxisome,	616278~Bile acid synthesis defect, congenital, 5,		SM00382:AAA,	Acetylation,Alternative splicing,ATP-binding,Complete proteome,Glycoprotein,Membrane,Nucleotide-binding,Peroxisome,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family D member 3,domain:ABC transmembrane type-1,domain:ABC transporter,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PEX19,region of interest:Targeting to peroxisomes,sequence conflict,sequence variant,splice variant,transmembrane region,
84126, 84126, 84126, 84126, 84126	ATR interacting protein(ATRIP)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0006260~DNA replication,GO:0036297~interstrand cross-link repair,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005654~nucleoplasm,	GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0070530~K63-linked polyubiquitin binding,		hsa03460:Fanconi anemia pathway,				3D-structure,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,Exonuclease,Hydrolase,Isopeptide bond,Nuclease,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:ATR-interacting protein,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,mutagenesis site,region of interest:Interaction with CINP,sequence conflict,sequence variant,short sequence motif:EEXXXDL motif,splice variant,
55814, 55814, 55814, 55814, 55814, 55814, 55814	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB(BDP1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0070898~RNA polymerase III transcriptional preinitiation complex assembly,	GO:0000126~transcription factor TFIIIB complex,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0001026~TFIIIB-type transcription factor activity,GO:0001156~TFIIIC-class transcription factor binding,GO:0003677~DNA binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,				SM00717:SANT,	Activator,Alternative splicing,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Transcription factor TFIIIB component B'' homolog,compositionally biased region:Ser-rich,domain:Myb-like,modified residue,mutagenesis site,region of interest:9 X 55 AA repeats of G-R-R-X-I-S-P-X-E-N- G-X-E-E-V-K-P-X-X-E-M-E-T-D-L-K-X-T-G-R- E-X-X-X-R-E-K-T-X-E-X-X-D-A-X-E-E-I-D-X- D-L-E-E-T,region of interest:Interaction with ZBTB43,region of interest:Required for phosphorylation by CSNK2A1,repeat:1; approximate,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8; approximate,repeat:9; approximate,sequence conflict,sequence variant,splice variant,
8314, 8314, 8314, 8314, 8314, 8314, 8314	BRCA1 associated protein 1(BAP1)	Homo sapiens				GO:0001558~regulation of cell growth,GO:0006464~cellular protein modification process,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016579~protein deubiquitination,GO:0035520~monoubiquitinated protein deubiquitination,GO:0035522~monoubiquitinated histone H2A deubiquitination,GO:0051726~regulation of cell cycle,GO:0071108~protein K48-linked deubiquitination,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035517~PR-DUB complex,	GO:0003682~chromatin binding,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR001578:Peptidase C12, ubiquitin carboxyl-terminal hydrolase 1,		614327~Tumor predisposition syndrome,			Chromatin regulator,Coiled coil,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase BAP1,modified residue,mutagenesis site,region of interest:Interaction with BRCA1,sequence variant,
83990, 83990, 83990, 83990, 83990, 83990	BRCA1 interacting protein C-terminal helicase 1(BRIP1)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006139~nucleobase-containing compound metabolic process,GO:0006260~DNA replication,GO:0006302~double-strand break repair,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0032508~DNA duplex unwinding,GO:0071295~cellular response to vitamin,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006554:Helicase-like, DEXD box c2 type,IPR006555:ATP-dependent helicase, C-terminal,IPR010614:DEAD2,IPR013020:DNA helicase (DNA repair), Rad3 type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014013:Helicase, superfamily 1/2, ATP-binding domain, DinG/Rad3-type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03460:Fanconi anemia pathway,	114480~Breast cancer, early-onset,609054~Fanconi anemia, complementation group J,		SM00487:DEXDc,SM00488:DEXDc2,SM00491:HELICc2,	3D-structure,4Fe-4S,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Direct protein sequencing,Disease mutation,DNA damage,DNA repair,Fanconi anemia,Helicase,Hydrolase,Iron,Iron-sulfur,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Fanconi anemia group J protein,domain:Helicase ATP-binding,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Interaction with BRCA1,sequence conflict,sequence variant,short sequence motif:DEAH box,short sequence motif:Nuclear localization signal,splice variant,
672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672, 672	BRCA1, DNA repair associated(BRCA1)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_bard1Pathway:BRCA1-dependent Ub-ligase activity,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_g2Pathway:Cell Cycle: G2/M Checkpoint,	Signal transduction mechanisms,	GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006633~fatty acid biosynthetic process,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007098~centrosome cycle,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0010212~response to ionizing radiation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0016567~protein ubiquitination,GO:0016925~protein sumoylation,GO:0030521~androgen receptor signaling pathway,GO:0031052~chromosome breakage,GO:0031398~positive regulation of protein ubiquitination,GO:0031572~G2 DNA damage checkpoint,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0035066~positive regulation of histone acetylation,GO:0035067~negative regulation of histone acetylation,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043009~chordate embryonic development,GO:0043627~response to estrogen,GO:0044030~regulation of DNA methylation,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046600~negative regulation of centriole replication,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0051574~positive regulation of histone H3-K9 methylation,GO:0051865~protein autoubiquitination,GO:0070512~positive regulation of histone H4-K20 methylation,GO:0071158~positive regulation of cell cycle arrest,GO:0071356~cellular response to tumor necrosis factor,GO:0071681~cellular response to indole-3-methanol,GO:0085020~protein K6-linked ubiquitination,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000620~positive regulation of histone H4-K16 acetylation,	GO:0000151~ubiquitin ligase complex,GO:0000794~condensed nuclear chromosome,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0008274~gamma-tubulin ring complex,GO:0016021~integral component of membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031436~BRCA1-BARD1 complex,GO:0043234~protein complex,GO:0070531~BRCA1-A complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044212~transcription regulatory region DNA binding,GO:0050681~androgen receptor binding,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR011364:Breast cancer type 1 susceptibility protein (BRCA1),IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR025994:BRCA1, serine-rich domain,IPR027370:RING-type zinc-finger, LisH dimerisation motif,	hsa03460:Fanconi anemia pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04151:PI3K-Akt signaling pathway,hsa05206:MicroRNAs in cancer,	604370~Breast-ovarian cancer, familial, 1,614320~Pancreatic cancer, susceptibility to, 4,	PIRSF001734:transcriptional regulator, BRCA1 type,	SM00184:RING,SM00292:BRCT,	3D-structure,Acetylation,Activator,Alternative initiation,Alternative splicing,Cell cycle,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA-binding,Fatty acid biosynthesis,Fatty acid metabolism,Isopeptide bond,Ligase,Lipid biosynthesis,Lipid metabolism,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Breast cancer type 1 susceptibility protein,compositionally biased region:Poly-Lys,domain:BRCT 1,domain:BRCT 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:RING-type,
582, 582, 582, 582, 582, 582, 582, 582, 582, 582	Bardet-Biedl syndrome 1(BBS1)	Homo sapiens				GO:0001895~retina homeostasis,GO:0007601~visual perception,GO:0035058~nonmotile primary cilium assembly,GO:0042384~cilium assembly,GO:0043001~Golgi to plasma membrane protein transport,GO:0045494~photoreceptor cell maintenance,GO:0050896~response to stimulus,GO:0060271~cilium morphogenesis,GO:0061512~protein localization to cilium,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0005930~axoneme,GO:0034464~BBSome,GO:0036064~ciliary basal body,GO:0060170~ciliary membrane,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0005113~patched binding,GO:0005119~smoothened binding,GO:0005515~protein binding,	IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,		209900~Bardet-Biedl syndrome 1,			Acetylation,Alternative splicing,Bardet-Biedl syndrome,Cell membrane,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Obesity,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Sensory transduction,Signal,Transport,Vision,	chain:Bardet-Biedl syndrome 1 protein,modified residue,sequence variant,splice variant,
8837, 8837, 8837, 8837, 8837, 8837, 8837, 8837, 8837, 8837, 8837, 8837, 8837	CASP8 and FADD like apoptosis regulator(CFLAR)	Homo sapiens	36.Death_of_Key_Intracellular_Targets,86.Apoptosis_Nematode&_Vert,	h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0007519~skeletal muscle tissue development,GO:0014732~skeletal muscle atrophy,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0014866~skeletal myofibril assembly,GO:0016032~viral process,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043403~skeletal muscle tissue regeneration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0060544~regulation of necroptotic process,GO:0097194~execution phase of apoptosis,GO:1901740~negative regulation of myoblast fusion,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0045121~membrane raft,GO:0097342~ripoptosome,	GO:0002020~protease binding,GO:0004197~cysteine-type endopeptidase activity,GO:0005123~death receptor binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0032403~protein complex binding,GO:0097200~cysteine-type endopeptidase activity involved in execution phase of apoptosis,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001875:Death effector domain,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,	hsa04064:NF-kappa B signaling pathway,hsa04210:Apoptosis,hsa04668:TNF signaling pathway,hsa05142:Chagas disease (American trypanosomiasis),			SM00031:DED,SM00115:CASc,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Host-virus interaction,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:CASP8 and FADD-like apoptosis regulator subunit p12,chain:CASP8 and FADD-like apoptosis regulator subunit p43,domain:DED 1,domain:DED 2,helix,mutagenesis site,region of interest:Caspase,region of interest:Interaction with caspase-3,region of interest:Interaction with caspase-8,region of interest:Interaction with caspase-8 propeptide,region of interest:Interaction with caspase-8 subunits p18 and p10,region of interest:Interaction with FADD,region of interest:Interaction with TRAF1 and TRAF2,region of interest:Not proteolytically processed and involved in apoptosis inhibition,sequence conflict,sequence variant,splice variant,strand,turn,
863, 863, 863, 863, 863, 863, 863, 863, 863, 863	CBFA2/RUNX1 translocation partner 3(CBFA2T3)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006351~transcription, DNA-templated,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030851~granulocyte differentiation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0045820~negative regulation of glycolytic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:1903715~regulation of aerobic respiration,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR002893:Zinc finger, MYND-type,IPR003894:TAFH/NHR1,IPR013289:Eight-Twenty-One,IPR013292:Myeloid transforming gene on chromosome 16 (MTG16),IPR014896:NHR2-like,				SM00549:TAFH,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Differentiation,Golgi apparatus,Isopeptide bond,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Protein CBFA2T3,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:TAFH,modified residue,mutagenesis site,region of interest:Mediates interaction with PDE7A (in isoform 2),region of interest:Mediates interaction with PRKAR2A,region of interest:Mediates localization to the nucleus,region of interest:Required for nucleolar targeting (in isoform 1),sequence conflict,sequence variant,site:Breakpoint for translocation to form type-1 RUNX1-CBFA2T3 fusion protein,site:Breakpoint for translocation to form type-2 RUNX1-CBFA2T3 fusion protein,splice variant,zinc finger region:MYND-type,
1050	CCAAT/enhancer binding protein alpha(CEBPA)	Homo sapiens		h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,		GO:0000050~urea cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006091~generation of precursor metabolites and energy,GO:0006351~transcription, DNA-templated,GO:0006360~transcription from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0007219~Notch signaling pathway,GO:0008203~cholesterol metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0016032~viral process,GO:0019221~cytokine-mediated signaling pathway,GO:0030099~myeloid cell differentiation,GO:0030225~macrophage differentiation,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042593~glucose homeostasis,GO:0045444~fat cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0048469~cell maturation,GO:0048839~inner ear development,GO:0050872~white fat cell differentiation,GO:0050873~brown fat cell differentiation,GO:0055088~lipid homeostasis,GO:0071285~cellular response to lithium ion,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001013~RNA polymerase I regulatory region DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0042803~protein homodimerization activity,GO:0044212~transcription regulatory region DNA binding,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,	hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,	601626~Leukemia, acute myeloid,601626~Leukemia, acute myeloid, somatic,	PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Acetylation,Activator,Alternative initiation,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein alpha,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,sequence conflict,
23607	CD2 associated protein(CD2AP)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006930~substrate-dependent cell migration, cell extension,GO:0007010~cytoskeleton organization,GO:0007067~mitotic nuclear division,GO:0007165~signal transduction,GO:0016050~vesicle organization,GO:0016337~single organismal cell-cell adhesion,GO:0032911~negative regulation of transforming growth factor beta1 production,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0048259~regulation of receptor-mediated endocytosis,GO:0051301~cell division,GO:1900182~positive regulation of protein localization to nucleus,GO:2000249~regulation of actin cytoskeleton reorganization,	GO:0001726~ruffle,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0015629~actin cytoskeleton,GO:0030139~endocytic vesicle,GO:0031941~filamentous actin,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,	hsa05100:Bacterial invasion of epithelial cells,	607832~Glomerulosclerosis, focal segmental, 3,		SM00326:SH3,	3D-structure,Cell cycle,Cell division,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Mitosis,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3 domain,SH3-binding,Ubl conjugation,	chain:CD2-associated protein,compositionally biased region:Pro-rich,domain:SH3 1; truncated,domain:SH3 2,domain:SH3 3,helix,modified residue,region of interest:Interaction with ANLN and localization to the midbody,sequence variant,short sequence motif:SH3-binding,strand,turn,
948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948, 948	CD36 molecule(CD36)	Homo sapiens		h_tsp1Pathway:TSP-1 Induced Apoptosis in Microvascular Endothelial Cell ,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001954~positive regulation of cell-matrix adhesion,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002576~platelet degranulation,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006629~lipid metabolic process,GO:0006898~receptor-mediated endocytosis,GO:0006910~phagocytosis, recognition,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007263~nitric oxide mediated signal transduction,GO:0007596~blood coagulation,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010886~positive regulation of cholesterol storage,GO:0019915~lipid storage,GO:0019934~cGMP-mediated signaling,GO:0030194~positive regulation of blood coagulation,GO:0030299~intestinal cholesterol absorption,GO:0030301~cholesterol transport,GO:0031623~receptor internalization,GO:0032735~positive regulation of interleukin-12 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033993~response to lipid,GO:0034197~triglyceride transport,GO:0034381~plasma lipoprotein particle clearance,GO:0034383~low-density lipoprotein particle clearance,GO:0035634~response to stilbenoid,GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway,GO:0042953~lipoprotein transport,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043277~apoptotic cell clearance,GO:0044130~negative regulation of growth of symbiont in host,GO:0044539~long-chain fatty acid import,GO:0050702~interleukin-1 beta secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050830~defense response to Gram-positive bacterium,GO:0050892~intestinal absorption,GO:0050909~sensory perception of taste,GO:0055096~low-density lipoprotein particle mediated signaling,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0060907~positive regulation of macrophage cytokine production,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070508~cholesterol import,GO:0070542~response to fatty acid,GO:0070543~response to linoleic acid,GO:0071221~cellular response to bacterial lipopeptide,GO:0071222~cellular response to lipopolysaccharide,GO:0071223~cellular response to lipoteichoic acid,GO:0071404~cellular response to low-density lipoprotein particle stimulus,GO:0071447~cellular response to hydroperoxide,GO:0071726~cellular response to diacyl bacterial lipopeptide,GO:1900227~positive regulation of NLRP3 inflammasome complex assembly,GO:1990000~amyloid fibril formation,GO:2000121~regulation of removal of superoxide radicals,GO:2000334~positive regulation of blood microparticle formation,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000505~regulation of energy homeostasis,	GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030666~endocytic vesicle membrane,GO:0031092~platelet alpha granule membrane,GO:0031526~brush border membrane,GO:0045121~membrane raft,GO:0045177~apical part of cell,GO:0045335~phagocytic vesicle,	GO:0005041~low-density lipoprotein receptor activity,GO:0005515~protein binding,GO:0008035~high-density lipoprotein particle binding,GO:0008289~lipid binding,GO:0030169~low-density lipoprotein particle binding,GO:0050431~transforming growth factor beta binding,GO:0070053~thrombospondin receptor activity,GO:0070892~lipoteichoic acid receptor activity,GO:0071813~lipoprotein particle binding,	IPR002159:CD36 antigen,IPR005428:Adhesion molecule CD36,	hsa03320:PPAR signaling pathway,hsa04145:Phagosome,hsa04152:AMPK signaling pathway,hsa04512:ECM-receptor interaction,hsa04640:Hematopoietic cell lineage,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa04975:Fat digestion and absorption,hsa05144:Malaria,	608404~Platelet glycoprotein IV deficiency,610938~Coronary heart disease, susceptibility to, 7,611162~Malaria, cerebral, reduced risk of,611162~Malaria, cerebral, susceptibility to,Macrothrombocytopenia~Macrothrombocytopenia,			3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Collagen,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Golgi apparatus,Isopeptide bond,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Platelet glycoprotein 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
55755, 55755, 55755, 55755, 55755, 55755, 55755, 55755, 55755, 55755, 55755, 55755, 55755	CDK5 regulatory subunit associated protein 2(CDK5RAP2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0000132~establishment of mitotic spindle orientation,GO:0000226~microtubule cytoskeleton organization,GO:0001578~microtubule bundle formation,GO:0007059~chromosome segregation,GO:0007099~centriole replication,GO:0007420~brain development,GO:0022008~neurogenesis,GO:0031023~microtubule organizing center organization,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046600~negative regulation of centriole replication,GO:0051297~centrosome organization,GO:0090231~regulation of spindle checkpoint,	GO:0000242~pericentriolar material,GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0035371~microtubule plus-end,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0097431~mitotic spindle pole,	GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008017~microtubule binding,GO:0015631~tubulin binding,GO:0019901~protein kinase binding,GO:0044212~transcription regulatory region DNA binding,	IPR012943:Spindle associated,		604804~Microcephaly 3, primary, autosomal recessive,			Alternative splicing,Calmodulin-binding,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Membrane,Mental retardation,Microtubule,Phosphoprotein,Polymorphism,Primary microcephaly,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CDK5 regulatory subunit-associated protein 2,modified residue,region of interest:Interaction with CDK5R1,sequence conflict,sequence variant,splice variant,
23624	Cbl proto-oncogene C(CBLC)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0016567~protein ubiquitination,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043407~negative regulation of MAP kinase activity,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0001784~phosphotyrosine binding,GO:0004871~signal transducer activity,GO:0005154~epidermal growth factor receptor binding,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0061630~ubiquitin protein ligase activity,	IPR000980:SH2 domain,IPR001841:Zinc finger, RING-type,IPR003153:Adaptor protein Cbl, N-terminal helical,IPR011992:EF-hand-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014741:Adaptor protein Cbl, EF hand-like,IPR014742:Adaptor protein Cbl, SH2-like,IPR017907:Zinc finger, RING-type, conserved site,IPR024159:Adaptor protein Cbl, PTB domain,IPR024162:Adaptor protein Cbl,	hsa04012:ErbB signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04660:T cell receptor signaling pathway,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05220:Chronic myeloid leukemia,			SM00184:RING,	3D-structure,Alternative splicing,Calcium,Complete proteome,Ligase,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3-binding,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Phosphotyrosine,chain:Signal transduction protein CBL-C,domain:CBL N-terminal,domain:EF-hand-like 1,domain:EF-hand-like 2,domain:SH2; atypical,modified residue,region of interest:4H,region of interest:Linker,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:RING-type,
867, 867, 867, 867, 867, 867	Cbl proto-oncogene(CBL)	Homo sapiens		h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,		GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007166~cell surface receptor signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007175~negative regulation of epidermal growth factor-activated receptor activity,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014823~response to activity,GO:0016567~protein ubiquitination,GO:0023051~regulation of signaling,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042594~response to starvation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0045471~response to ethanol,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0070997~neuron death,GO:0090650~cellular response to oxygen-glucose deprivation,GO:0098609~cell-cell adhesion,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016600~flotillin complex,GO:0030426~growth cone,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0001784~phosphotyrosine binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017124~SH3 domain binding,GO:0030971~receptor tyrosine kinase binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0046875~ephrin receptor binding,GO:0061630~ubiquitin protein ligase activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000980:SH2 domain,IPR001841:Zinc finger, RING-type,IPR003153:Adaptor protein Cbl, N-terminal helical,IPR009060:UBA-like,IPR011992:EF-hand-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014741:Adaptor protein Cbl, EF hand-like,IPR014742:Adaptor protein Cbl, SH2-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR017907:Zinc finger, RING-type, conserved site,IPR024159:Adaptor protein Cbl, PTB domain,IPR024162:Adaptor protein Cbl,	hsa04012:ErbB signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04660:T cell receptor signaling pathway,hsa04910:Insulin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05220:Chronic myeloid leukemia,	613563~Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia,		SM00165:UBA,SM00184:RING,	3D-structure,Calcium,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Ligase,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Signal,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Phosphotyrosine,chain:E3 ubiquitin-protein ligase CBL,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Pro-rich,domain:CBL N-terminal,domain:EF-hand-like 1,domain:EF-hand-like 2,domain:SH2; atypical,domain:UBA,helix,modified residue,mutagenesis site,region of interest:4H,region of interest:Interaction with CD2AP,region of interest:Linker,sequence conflict,sequence variant,strand,turn,zinc finger region:RING-type,
100526767	RNF103-CHMP3 readthrough(RNF103-CHMP3)	Homo sapiens				GO:0000920~cell separation after cytokinesis,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0007034~vacuolar transport,GO:0007049~cell cycle,GO:0010824~regulation of centrosome duplication,GO:0015031~protein transport,GO:0016197~endosomal transport,GO:0019058~viral life cycle,GO:0036258~multivesicular body assembly,GO:0039702~viral budding via host ESCRT complex,GO:0050792~regulation of viral process,GO:0051258~protein polymerization,GO:0051291~protein heterooligomerization,GO:0061763~multivesicular body-lysosome fusion,GO:0071985~multivesicular body sorting pathway,GO:0097352~autophagosome maturation,GO:1902187~negative regulation of viral release from host cell,GO:1902188~positive regulation of viral release from host cell,GO:2000641~regulation of early endosome to late endosome transport,	GO:0000815~ESCRT III complex,GO:0005622~intracellular,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031902~late endosome membrane,GO:0070062~extracellular exosome,	GO:0031210~phosphatidylcholine binding,GO:0042803~protein homodimerization activity,GO:1990381~ubiquitin-specific protease binding,	IPR005024:Snf7,	hsa04144:Endocytosis,				3D-structure,Alternative splicing,Apoptosis,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Endosome,Isopeptide bond,Lipoprotein,Membrane,Myristate,Phosphoprotein,Protein transport,Reference proteome,Transport,Ubl conjugation,
468, 468	activating transcription factor 4(ATF4)	Homo sapiens				GO:0006094~gluconeogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006520~cellular amino acid metabolic process,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0032057~negative regulation of translational initiation in response to stress,GO:0032922~circadian regulation of gene expression,GO:0034198~cellular response to amino acid starvation,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0036091~positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0036499~PERK-mediated unfolded protein response,GO:0042149~cellular response to glucose starvation,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043065~positive regulation of apoptotic process,GO:0043267~negative regulation of potassium ion transport,GO:0043525~positive regulation of neuron apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061395~positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:1990737~response to manganese-induced endoplasmic reticulum stress,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0032590~dendrite membrane,GO:0034399~nuclear periphery,GO:0043005~neuron projection,GO:1990037~Lewy body core,GO:1990589~ATF4-CREB1 transcription factor complex,GO:1990590~ATF1-ATF4 transcription factor complex,GO:1990617~CHOP-ATF4 complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0043522~leucine zipper domain binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04151:PI3K-Akt signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04668:TNF signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04728:Dopaminergic synapse,hsa04911:Insulin secretion,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04918:Thyroid hormone synthesis,hsa04922:Glucagon signaling pathway,hsa04925:Aldosterone synthesis and secretion,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,hsa05215:Prostate cancer,			SM00338:BRLZ,	3D-structure,Activator,Biological rhythms,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,Isopeptide bond,Lipoprotein,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Cyclic AMP-dependent transcription factor ATF-4,DNA-binding region:Basic motif,domain:Leucine-zipper,helix,modified residue,region of interest:Interaction with GABBR1,sequence conflict,sequence variant,
22809, 22809, 22809, 22809, 22809	activating transcription factor 5(ATF5)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0008285~negative regulation of cell proliferation,GO:0009791~post-embryonic development,GO:0021891~olfactory bulb interneuron development,GO:0021930~cerebellar granule cell precursor proliferation,GO:0035264~multicellular organism growth,GO:0043066~negative regulation of apoptotic process,GO:0045444~fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046605~regulation of centrosome cycle,GO:1902750~negative regulation of cell cycle G2/M phase transition,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005813~centrosome,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0015631~tubulin binding,GO:0019900~kinase binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR004827:Basic-leucine zipper domain,				SM00338:BRLZ,	Acetylation,Activator,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Cyclic AMP-dependent transcription factor ATF-5,compositionally biased region:Poly-Pro,DNA-binding region:Basic motif,domain:Leucine-zipper,region of interest:Interaction with PTP4A1,sequence conflict,sequence variant,
57379, 57379, 57379, 57379, 57379, 57379, 57379, 57379, 57379	activation induced cytidine deaminase(AICDA)	Homo sapiens				GO:0006397~mRNA processing,GO:0009972~cytidine deamination,GO:0016445~somatic diversification of immunoglobulins,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0030183~B cell differentiation,GO:0045190~isotype switching,GO:0071222~cellular response to lipopolysaccharide,GO:0080111~DNA demethylation,GO:0090310~negative regulation of methylation-dependent chromatin silencing,	GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004126~cytidine deaminase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016814~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,GO:0031625~ubiquitin protein ligase binding,	IPR002125:CMP/dCMP deaminase, zinc-binding,IPR013158:APOBEC-like, N-terminal,IPR016192:APOBEC/CMP deaminase, zinc-binding,IPR016193:Cytidine deaminase-like,	hsa04672:Intestinal immune network for IgA production,hsa05340:Primary immunodeficiency,	605258~Immunodeficiency with hyper-IgM, type 2,			3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Metal-binding,mRNA processing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,	active site:Proton donor,chain:Activation-induced cytidine deaminase,metal ion-binding site:Zinc; catalytic,sequence variant,
119, 119, 119, 119, 119, 119, 119	adducin 2(ADD2)	Homo sapiens				GO:0006461~protein complex assembly,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0032092~positive regulation of protein binding,GO:0051016~barbed-end actin filament capping,GO:0051017~actin filament bundle assembly,GO:0055085~transmembrane transport,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0008290~F-actin capping protein complex,GO:0014069~postsynaptic density,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005516~calmodulin binding,GO:0030507~spectrin binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0051015~actin filament binding,	IPR001303:Class II aldolase/adducin N-terminal,				SM01007:SM01007,	Acetylation,Actin-binding,Alternative splicing,Calmodulin-binding,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Beta-adducin,modified residue,region of interest:Interaction with calmodulin,sequence variant,splice variant,
65057, 65057, 65057, 65057, 65057	adrenocortical dysplasia homolog(ACD)	Homo sapiens				GO:0000723~telomere maintenance,GO:0001501~skeletal system development,GO:0001655~urogenital system development,GO:0006886~intracellular protein transport,GO:0007004~telomere maintenance via telomerase,GO:0016233~telomere capping,GO:0030326~embryonic limb morphogenesis,GO:0031848~protection from non-homologous end joining at telomere,GO:0032202~telomere assembly,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0035282~segmentation,GO:0051973~positive regulation of telomerase activity,GO:0060381~positive regulation of single-stranded telomeric DNA binding,GO:0070198~protein localization to chromosome, telomeric region,GO:0070200~establishment of protein localization to telomere,	GO:0000783~nuclear telomere cap complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070187~telosome,	GO:0005515~protein binding,GO:0042162~telomeric DNA binding,GO:0044877~macromolecular complex binding,GO:0070182~DNA polymerase binding,			616553~Dyskeratosis congenita, autosomal dominant 6,616553~Dyskeratosis congenita, autosomal recessive 7,			3D-structure,Alternative splicing,Chromosome,Complete proteome,Disease mutation,DNA-binding,Dyskeratosis congenita,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,	chain:Adrenocortical dysplasia protein homolog,compositionally biased region:Ser-rich,helix,modified residue,region of interest:Interaction with POT1,sequence conflict,sequence variant,short sequence motif:PWI,splice variant,strand,
290, 290, 290, 290, 290, 290	alanyl aminopeptidase, membrane(ANPEP)	Homo sapiens		h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,h_SARSpathway:SARS Coronavirus Protease,	Amino acid transport and metabolism,	GO:0001525~angiogenesis,GO:0006508~proteolysis,GO:0030154~cell differentiation,GO:0043171~peptide catabolic process,GO:0046718~viral entry into host cell,	GO:0005615~extracellular space,GO:0005765~lysosomal membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0004177~aminopeptidase activity,GO:0004872~receptor activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0042277~peptide binding,GO:0070006~metalloaminopeptidase activity,	IPR001930:Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase,IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal,IPR024571:Domain of unknown function DUF3358,	hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa04614:Renin-angiotensin system,hsa04640:Hematopoietic cell lineage,				3D-structure,Aminopeptidase,Angiogenesis,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Sulfation,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,chain:Aminopeptidase N,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,modified residue,mutagenesis site,region of interest:Cytosolic Ser/Thr-rich junction,region of interest:Interaction with HCoV-229E,region of interest:Metalloprotease,sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,
9255, 9255	aminoacyl tRNA synthetase complex interacting multifunctional protein 1(AIMP1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006006~glucose metabolic process,GO:0006418~tRNA aminoacylation for protein translation,GO:0006915~apoptotic process,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0009611~response to wounding,GO:0050900~leukocyte migration,GO:0051607~defense response to virus,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0009986~cell surface,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0017102~methionyl glutamyl tRNA synthetase complex,GO:0030133~transport vesicle,	GO:0000049~tRNA binding,GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0051020~GTPase binding,	IPR002547:tRNA-binding domain,IPR012340:Nucleic acid-binding, OB-fold,		260600~Leukodystrophy, hypomyelinating, 3,			3D-structure,Acetylation,Alternative splicing,Angiogenesis,Apoptosis,Carbohydrate metabolism,Cell adhesion,Coiled coil,Complete proteome,Cytokine,Cytoplasm,Cytoplasmic vesicle,Endoplasmic reticulum,Glucose metabolism,Golgi apparatus,Inflammatory response,Isopeptide bond,Leukodystrophy,Nucleus,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Secreted,tRNA-binding,Ubl conjugation,	chain:Aminoacyl tRNA synthetase complex- interacting multifunctional protein 1,chain:Endothelial monocyte-activating polypeptide 2,domain:tRNA-binding,helix,modified residue,region of interest:Interaction with HSP90B1,region of interest:Required for endothelial cell death,region of interest:Required for endothelial cell migration,region of interest:Required for fibroblast proliferation,sequence variant,strand,turn,
7965, 7965, 7965, 7965	aminoacyl tRNA synthetase complex interacting multifunctional protein 2(AIMP2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0006418~tRNA aminoacylation for protein translation,GO:0006915~apoptotic process,GO:0008285~negative regulation of cell proliferation,GO:0031398~positive regulation of protein ubiquitination,GO:0060510~Type II pneumocyte differentiation,GO:1901216~positive regulation of neuron death,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,	IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,					3D-structure,Apoptosis,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Nucleus,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Aminoacyl tRNA synthetase complex- interacting multifunctional protein 2,chain:STAG3-like protein,domain:GST C-terminal,domain:SCD,mutagenesis site,region of interest:Interaction with PARK2,region of interest:Interaction with TP53,sequence conflict,sequence variant,splice variant,
367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367, 367	androgen receptor(AR)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0003073~regulation of systemic arterial blood pressure,GO:0003382~epithelial cell morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006810~transport,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007283~spermatogenesis,GO:0007338~single fertilization,GO:0007548~sex differentiation,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0019102~male somatic sex determination,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor signaling pathway,GO:0030850~prostate gland development,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0033327~Leydig cell differentiation,GO:0035264~multicellular organism growth,GO:0042327~positive regulation of phosphorylation,GO:0043410~positive regulation of MAPK cascade,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0045597~positive regulation of cell differentiation,GO:0045720~negative regulation of integrin biosynthetic process,GO:0045726~positive regulation of integrin biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0048638~regulation of developmental growth,GO:0048645~organ formation,GO:0048808~male genitalia morphogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050790~regulation of catalytic activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051259~protein oligomerization,GO:0060520~activation of prostate induction by androgen receptor signaling pathway,GO:0060571~morphogenesis of an epithelial fold,GO:0060599~lateral sprouting involved in mammary gland duct morphogenesis,GO:0060736~prostate gland growth,GO:0060740~prostate gland epithelium morphogenesis,GO:0060742~epithelial cell differentiation involved in prostate gland development,GO:0060748~tertiary branching involved in mammary gland duct morphogenesis,GO:0060749~mammary gland alveolus development,GO:0072520~seminiferous tubule development,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004882~androgen receptor activity,GO:0005102~receptor binding,GO:0005496~steroid binding,GO:0005497~androgen binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,GO:0051117~ATPase binding,GO:0070974~POU domain binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001103:Androgen receptor,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,	hsa04114:Oocyte meiosis,hsa05200:Pathways in cancer,hsa05215:Prostate cancer,	176807~Prostate cancer, susceptibility to,300068~Androgen insensitivity,300633~Hypospadias 1, X-linked,312300~Androgen insensitivity, partial, with or without breast cancer,313200~Spinal and bulbar muscular atrophy of Kennedy,		SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Activator,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Lipid-binding,Lipoprotein,Membrane,Metal-binding,Neurodegeneration,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Pseudohermaphroditism,Receptor,Reference proteome,Steroid-binding,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Triplet repeat expansion,Ubl conjugation,Zinc,Zinc-finger,	binding site:Androgen,chain:Androgen receptor,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Nuclear receptor,helix,modified residue,mutagenesis site,region of interest:Interaction with HIPK3,region of interest:Interaction with MYST2,region of interest:Ligand-binding,region of interest:Modulating,sequence conflict,sequence variant,site:Interaction with coactivator FXXLF motif,site:Interaction with coactivator LXXL motif,splice variant,strand,zinc finger region:NR C4-type,
27063	ankyrin repeat domain 1(ANKRD1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0010976~positive regulation of neuron projection development,GO:0035690~cellular response to drug,GO:0035914~skeletal muscle cell differentiation,GO:0035994~response to muscle stretch,GO:0042692~muscle cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045214~sarcomere organization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050714~positive regulation of protein secretion,GO:0055008~cardiac muscle tissue morphogenesis,GO:0071222~cellular response to lipopolysaccharide,GO:0071260~cellular response to mechanical stimulus,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,GO:0071456~cellular response to hypoxia,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030017~sarcomere,GO:0031674~I band,	GO:0001085~RNA polymerase II transcription factor binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0031432~titin binding,GO:0042826~histone deacetylase binding,GO:0070412~R-SMAD binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Coiled coil,Complete proteome,Disease mutation,Nucleus,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 1,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence conflict,sequence variant,
84079, 84079, 84079, 84079, 84079, 84079, 84079	ankyrin repeat domain 27(ANKRD27)	Homo sapiens				GO:0015031~protein transport,GO:0035544~negative regulation of SNARE complex assembly,GO:0035646~endosome to melanosome transport,GO:0043547~positive regulation of GTPase activity,GO:0045022~early endosome to late endosome transport,GO:0048812~neuron projection morphogenesis,GO:0050775~positive regulation of dendrite morphogenesis,GO:1990126~retrograde transport, endosome to plasma membrane,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030133~transport vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0042470~melanosome,GO:0043005~neuron projection,GO:0097422~tubular endosome,	GO:0000149~SNARE binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0017137~Rab GTPase binding,	IPR002110:Ankyrin repeat,IPR003123:Vacuolar sorting protein 9,IPR020683:Ankyrin repeat-containing domain,				SM00167:VPS9,SM00248:ANK,	3D-structure,ANK repeat,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endosome,GTPase activation,Guanine-nucleotide releasing factor,Lysosome,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Ankyrin repeat domain-containing protein 27,domain:VPS9,modified residue,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,
6310, 6310, 6310, 6310	ataxin 1(ATXN1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006396~RNA processing,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051168~nuclear export,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0042272~nuclear RNA export factor complex,GO:0042405~nuclear inclusion body,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008266~poly(U) RNA binding,GO:0034046~poly(G) binding,GO:0042802~identical protein binding,GO:0043621~protein self-association,	IPR003652:Ataxin, AXH domain,IPR020997:Capicua transcriptional repressor modulator, Ataxin-1,		164400~Spinocerebellar ataxia 1,		SM00536:AXH,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Neurodegeneration,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repressor,RNA-binding,Spinocerebellar ataxia,Transcription,Transcription regulation,Triplet repeat expansion,Ubl conjugation,	chain:Ataxin-1,compositionally biased region:Poly-Gln,domain:AXH,helix,modified residue,region of interest:Interaction with USP7,region of interest:RNA-binding,region of interest:Self-association,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
23621, 23621, 23621, 23621, 23621, 23621, 23621, 23621, 23621, 23621, 23621	beta-secretase 1(BACE1)	Homo sapiens		h_appPathway:Generation of amyloid b-peptide by PS1,		GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0030163~protein catabolic process,GO:0044267~cellular protein metabolic process,GO:0050435~beta-amyloid metabolic process,	GO:0005768~endosome,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0045121~membrane raft,GO:0070931~Golgi-associated vesicle lumen,	GO:0001540~beta-amyloid binding,GO:0004190~aspartic-type endopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008798~beta-aspartyl-peptidase activity,GO:0019899~enzyme binding,	IPR001461:Peptidase A1,IPR001969:Peptidase aspartic, active site,IPR009119:Peptidase A1, beta-site APP cleaving enzyme, BACE,IPR009120:Peptidase A1, beta-site APP cleaving enzyme 1, BACE 1,IPR021109:Aspartic peptidase,	hsa05010:Alzheimer's disease,				3D-structure,Acetylation,Alternative splicing,Aspartyl protease,Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Hydrolase,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zymogen,	chain:Beta-secretase 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Interaction with RTN3,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
274, 274, 274, 274, 274, 274, 274, 274, 274, 274, 274, 274, 274	bridging integrator 1(BIN1)	Homo sapiens	62.G1-phase_progression_by_Myc,			GO:0006897~endocytosis,GO:0006997~nucleus organization,GO:0008283~cell proliferation,GO:0016032~viral process,GO:0030100~regulation of endocytosis,GO:0042692~muscle cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0045664~regulation of neuron differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0051647~nucleus localization,GO:0060988~lipid tube assembly,GO:0071156~regulation of cell cycle arrest,	GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030018~Z disc,GO:0030315~T-tubule,GO:0030424~axon,GO:0031674~I band,GO:0033268~node of Ranvier,GO:0043194~axon initial segment,GO:0060987~lipid tube,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0048156~tau protein binding,GO:0051015~actin filament binding,GO:0070063~RNA polymerase binding,	IPR001452:Src homology-3 domain,IPR003005:Amphiphysin,IPR003023:Amphiphysin, isoform 2,IPR004148:BAR domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,	hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,	255200~Myopathy, centronuclear, autosomal recessive,		SM00326:SH3,SM00721:BAR,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,Endocytosis,Host-virus interaction,Nucleus,Phosphoprotein,Reference proteome,SH3 domain,Tumor suppressor,	chain:Myc box-dependent-interacting protein 1,domain:BAR,domain:SH3,helix,modified residue,region of interest:Clathrin-binding,region of interest:Interaction with BIN2,sequence conflict,sequence variant,splice variant,strand,
51411, 51411, 51411, 51411, 51411, 51411	bridging integrator 2(BIN2)	Homo sapiens				GO:0006911~phagocytosis, engulfment,GO:0060326~cell chemotaxis,GO:0071800~podosome assembly,GO:0097320~membrane tubulation,	GO:0001891~phagocytic cup,GO:0002102~podosome,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0030054~cell junction,GO:0042995~cell projection,	GO:0005515~protein binding,GO:0005543~phospholipid binding,	IPR003005:Amphiphysin,IPR004148:BAR domain,IPR027267:Arfaptin homology (AH) domain/BAR domain,				SM00721:BAR,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Bridging integrator 2,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:BAR,modified residue,sequence conflict,sequence variant,splice variant,
846, 846, 846, 846, 846, 846, 846, 846, 846, 846	calcium sensing receptor(CASR)	Homo sapiens				GO:0001503~ossification,GO:0005513~detection of calcium ion,GO:0006874~cellular calcium ion homeostasis,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007635~chemosensory behavior,GO:0009653~anatomical structure morphogenesis,GO:0070509~calcium ion import,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,	IPR000337:GPCR, family 3,IPR001828:Extracellular ligand-binding receptor,IPR011500:GPCR, family 3, nine cysteines domain,IPR017978:GPCR, family 3, C-terminal,IPR017979:GPCR, family 3, conserved site,		145980~Hypocalciuric hypercalcemia, type I,239200~Hyperparathyroidism, neonatal,601198~Hypocalcemia, autosomal dominant,601198~Hypocalcemia, autosomal dominant, with Bartter syndrome,612899~Epilepsy idiopathic generalized, susceptibility to, 8,Calcium, serum level of~Calcium, serum level of,Hypercalciuric hypercalcemia~Hypercalciuric hypercalcemia,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Epilepsy,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Extracellular calcium-sensing receptor,glycosylation site:N-linked (GlcNAc...),region of interest:Interaction with RNF19A,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
57805, 57805, 57805, 57805, 57805, 57805, 57805, 57805, 57805, 57805	cell cycle and apoptosis regulator 2(CCAR2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0009411~response to UV,GO:0016055~Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0031647~regulation of protein stability,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0042752~regulation of circadian rhythm,GO:0043065~positive regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090311~regulation of protein deacetylation,GO:1900034~regulation of cellular response to heat,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:2000003~positive regulation of DNA damage checkpoint,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0044609~DBIRD complex,	GO:0000993~RNA polymerase II core binding,GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR011992:EF-hand-like domain,IPR025223:S1-like RNA binding domain,IPR025224:DBC1/CARP1,IPR025954:DBC1/CARP1 catalytically inactive NUDIX hydrolase domain,				SM01122:SM01122,	Acetylation,Activator,Alternative splicing,Apoptosis,Biological rhythms,Cell cycle,Coiled coil,Complete proteome,Cytoplasm,DNA damage,Isopeptide bond,Metalloenzyme inhibitor,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Protein KIAA1967,modified residue,mutagenesis site,sequence conflict,splice variant,
9236, 9236, 9236, 9236, 9236, 9236, 9236, 9236, 9236	cell cycle progression 1(CCPG1)	Homo sapiens				GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0045787~positive regulation of cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:2001106~regulation of Rho guanyl-nucleotide exchange factor activity,	GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Alternative splicing,Cell cycle,Coiled coil,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Cell cycle progression protein 1,compositionally biased region:Poly-Arg,modified residue,region of interest:Interaction with MCF2L and SRC,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
55664, 55664	cell division cycle 37 like 1(CDC37L1)	Homo sapiens				GO:0002576~platelet degranulation,GO:0006457~protein folding,GO:0050821~protein stabilization,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0031089~platelet dense granule lumen,	GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR004918:Cdc37,IPR013874:Cdc37, Hsp90 binding,				SM01070:SM01070,	Chaperone,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Hsp90 co-chaperone Cdc37-like 1,modified residue,region of interest:Interaction with HSP70,region of interest:Required for interaction with STIP1,region of interest:Self-association,region of interest:Self-association and interaction with Hsp90,sequence conflict,sequence variant,
988	cell division cycle 5 like(CDC5L)	Homo sapiens			Transcription / RNA processing and modification / Cell division and chromosome partitioning,	GO:0000278~mitotic cell cycle,GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030154~cell differentiation,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0071352~cellular response to interleukin-2,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:1904568~cellular response to wortmannin,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990646~cellular response to prolactin,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0032993~protein-DNA complex,GO:0048471~perinuclear region of cytoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008157~protein phosphatase 1 binding,GO:0019901~protein kinase binding,GO:0043522~leucine zipper domain binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0071987~WD40-repeat domain binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017930:Myb domain,IPR021786:Domain of unknown function DUF3351,	hsa03040:Spliceosome,			SM00717:SANT,	3D-structure,Activator,Cell cycle,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,DNA damage,DNA repair,DNA-binding,Isopeptide bond,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,RNA-binding,Spliceosome,Transcription,Transcription regulation,Ubl conjugation,	chain:Cell division cycle 5-like protein,DNA-binding region:H-T-H motif,domain:HTH myb-type 1,domain:HTH myb-type 2,helix,modified residue,mutagenesis site,region of interest:Interaction with DAPK3,region of interest:Interaction with PLRG1,region of interest:Interaction with PPP1R8,sequence conflict,sequence variant,site:Breakpoint for translocation,strand,
79577, 79577, 79577, 79577	cell division cycle 73(CDC73)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006378~mRNA polyadenylation,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010390~histone monoubiquitination,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0019827~stem cell population maintenance,GO:0030177~positive regulation of Wnt signaling pathway,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0031648~protein destabilization,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0033523~histone H2B ubiquitination,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051301~cell division,GO:0071222~cellular response to lipopolysaccharide,GO:1904837~beta-catenin-TCF complex assembly,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016593~Cdc73/Paf1 complex,	GO:0000993~RNA polymerase II core binding,GO:0005515~protein binding,	IPR007852:RNA polymerase II accessory factor, Cdc73,		145000~Hyperparathyroidism, familial primary,145001~Hyperparathyroidism-jaw tumor syndrome,145001~Parathyroid adenoma with cystic changes,608266~Parathyroid carcinoma,			Acetylation,Cell cycle,Cell division,Complete proteome,Direct protein sequencing,Disease mutation,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Wnt signaling pathway,	chain:Parafibromin,compositionally biased region:Poly-Ile,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
9738, 9738, 9738, 9738	centriolar coiled-coil protein 110(CCP110)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007099~centriole replication,GO:0032053~ciliary basal body organization,GO:0032465~regulation of cytokinesis,GO:0045724~positive regulation of cilium assembly,GO:0051298~centrosome duplication,GO:1902018~negative regulation of cilium assembly,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0005929~cilium,GO:0043234~protein complex,	GO:0005515~protein binding,						Alternative splicing,Cell projection,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Centrosomal protein of 110 kDa,modified residue,region of interest:Calmodulin-binding,region of interest:CEP97 binding,region of interest:Interaction with CEP76,sequence conflict,sequence variant,splice variant,
55835, 55835, 55835, 55835, 55835	centromere protein J(CENPJ)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007020~microtubule nucleation,GO:0007099~centriole replication,GO:0007224~smoothened signaling pathway,GO:0035058~nonmotile primary cilium assembly,GO:0046599~regulation of centriole replication,GO:0046785~microtubule polymerization,GO:0051301~cell division,GO:0061511~centriole elongation,GO:1902857~positive regulation of nonmotile primary cilium assembly,GO:1903887~motile primary cilium assembly,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0005874~microtubule,GO:0008275~gamma-tubulin small complex,GO:0036064~ciliary basal body,	GO:0005515~protein binding,GO:0015631~tubulin binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,	IPR009852:T-complex protein 10, C-terminal domain,IPR026581:T-complex protein 10 family,		608393~Microcephaly 6, primary, autosomal recessive,613676~Seckel syndrome 4,			3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Dwarfism,Mental retardation,Microtubule,Phosphoprotein,Polymorphism,Primary microcephaly,Proteomics identification,Reference proteome,	chain:Centromere protein J,modified residue,sequence conflict,sequence variant,
22995, 22995, 22995, 22995, 22995	centrosomal protein 152(CEP152)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007099~centriole replication,GO:0030030~cell projection organization,GO:0051298~centrosome duplication,GO:0098535~de novo centriole assembly,	GO:0000242~pericentriolar material,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0098536~deuterosome,	GO:0005515~protein binding,GO:0019901~protein kinase binding,			613823~Seckel syndrome 5,614852~Microcephaly 9, primary, autosomal recessive,			3D-structure,Alternative splicing,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Dwarfism,Mental retardation,Phosphoprotein,Polymorphism,Primary microcephaly,Proteomics identification,Reference proteome,	chain:Centrosomal protein of 152 kDa,modified residue,sequence conflict,sequence variant,splice variant,
22897, 22897, 22897, 22897, 22897, 22897	centrosomal protein 164(CEP164)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0006281~DNA repair,GO:0007067~mitotic nuclear division,GO:0042384~cilium assembly,GO:0051301~cell division,GO:0060271~cilium morphogenesis,	GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0097539~ciliary transition fiber,	GO:0005515~protein binding,	IPR001202:WW domain,		614845~Nephronophthisis 15,		SM00456:WW,	Alternative splicing,Cell cycle,Cell division,Ciliopathy,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,DNA damage,DNA repair,Mitosis,Nephronophthisis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Centrosomal protein of 164 kDa,compositionally biased region:Glu-rich,compositionally biased region:Lys-rich,domain:WW,modified residue,mutagenesis site,region of interest:Interaction with ATRIP,sequence conflict,sequence variant,splice variant,
80184, 80184, 80184, 80184, 80184, 80184, 80184, 80184, 80184	centrosomal protein 290(CEP290)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0015031~protein transport,GO:0030902~hindbrain development,GO:0030916~otic vesicle formation,GO:0042384~cilium assembly,GO:0042462~eye photoreceptor cell development,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048793~pronephros development,GO:0060271~cilium morphogenesis,GO:0070201~regulation of establishment of protein localization,GO:0090316~positive regulation of intracellular protein transport,	GO:0000930~gamma-tubulin complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0032391~photoreceptor connecting cilium,GO:0034451~centriolar satellite,GO:0035869~ciliary transition zone,GO:0036038~MKS complex,GO:0036064~ciliary basal body,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0051011~microtubule minus-end binding,	IPR026201:Centrosomal protein of 290kDa,		610188~Joubert syndrome 5,610189~Senior-Loken syndrome 6,611134~Meckel syndrome 4,611755~Leber congenital amaurosis 10,615991~Bardet-Biedl syndrome 14,			Activator,Alternative splicing,Bardet-Biedl syndrome,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Cytoskeleton,Disease mutation,Joubert syndrome,Leber congenital amaurosis,Meckel syndrome,Mental retardation,Nephronophthisis,Nucleus,Obesity,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Senior-Loken syndrome,Transport,Ubl conjugation,	chain:Centrosomal protein of 290 kDa,modified residue,sequence conflict,sequence variant,splice variant,
79959, 79959, 79959, 79959, 79959, 79959	centrosomal protein 76(CEP76)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0046599~regulation of centriole replication,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0043234~protein complex,	GO:0005515~protein binding,						Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Centrosomal protein of 76 kDa,modified residue,sequence conflict,splice variant,
1111, 1111, 1111, 1111, 1111, 1111, 1111, 1111, 1111, 1111, 1111, 1111	checkpoint kinase 1(CHEK1)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,		GO:0000077~DNA damage checkpoint,GO:0000086~G2/M transition of mitotic cell cycle,GO:0001833~inner cell mass cell proliferation,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006997~nucleus organization,GO:0007093~mitotic cell cycle checkpoint,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0010767~regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,GO:0018107~peptidyl-threonine phosphorylation,GO:0031572~G2 DNA damage checkpoint,GO:0035407~histone H3-T11 phosphorylation,GO:0042127~regulation of cell proliferation,GO:0045839~negative regulation of mitotic nuclear division,GO:0046602~regulation of mitotic centrosome separation,GO:0048096~chromatin-mediated maintenance of transcription,GO:0071260~cellular response to mechanical stimulus,GO:0090399~replicative senescence,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902742~apoptotic process involved in development,GO:2000615~regulation of histone H3-K9 acetylation,	GO:0000781~chromosome, telomeric region,GO:0000785~chromatin,GO:0000794~condensed nuclear chromosome,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005813~centrosome,GO:0005829~cytosol,GO:0043231~intracellular membrane-bounded organelle,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0035402~histone kinase activity (H3-T11 specific),	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,DNA damage,DNA repair,Isopeptide bond,Kinase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase chk1,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Autoinhibitory region,sequence variant,strand,turn,
81620, 81620, 81620	chromatin licensing and DNA replication factor 1(CDT1)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,		GO:0000076~DNA replication checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0033262~regulation of nuclear cell cycle DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014939:CDT1 Geminin-binding domain-like,		613804~Meier-Gorlin syndrome 4,		SM01075:SM01075,	3D-structure,Cell cycle,Complete proteome,Disease mutation,DNA replication,DNA-binding,Dwarfism,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Ubl conjugation,	chain:DNA replication factor Cdt1,modified residue,mutagenesis site,region of interest:Interaction with GMNN,sequence conflict,sequence variant,short sequence motif:Cyclin-binding motif,
9575, 9575, 9575	clock circadian regulator(CLOCK)	Homo sapiens		h_circadianPathway:Circadian Rhythms,		GO:0000077~DNA damage checkpoint,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0007623~circadian rhythm,GO:0009648~photoperiodism,GO:0016573~histone acetylation,GO:0032922~circadian regulation of gene expression,GO:0042634~regulation of hair cycle,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050729~positive regulation of inflammatory response,GO:0050796~regulation of insulin secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051775~response to redox state,GO:0071479~cellular response to ionizing radiation,GO:2000074~regulation of type B pancreatic cell development,GO:2000323~negative regulation of glucocorticoid receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0033391~chromatoid body,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,	IPR000014:PAS domain,IPR001067:Nuclear translocator,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013767:PAS fold,	hsa04710:Circadian rhythm,hsa04728:Dopaminergic synapse,hsa05168:Herpes simplex infection,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	3D-structure,Activator,Acyltransferase,Biological rhythms,Coiled coil,Complete proteome,Cytoplasm,DNA damage,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Ubl conjugation,	chain:Circadian locomoter output cycles protein kaput,compositionally biased region:Gln-rich,compositionally biased region:Poly-Gln,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,modified residue,mutagenesis site,region of interest:Implicated in the circadian rhythmicity,sequence conflict,sequence variant,
51550, 51550, 51550, 51550	cyclin dependent kinase 2 interacting protein(CINP)	Homo sapiens				GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0007049~cell cycle,GO:0051301~cell division,	GO:0005634~nucleus,	GO:0005515~protein binding,GO:0016301~kinase activity,	IPR023250:Cyclin-dependent kinase 2-interacting protein,					Acetylation,Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,DNA damage,DNA repair,DNA replication,Kinase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Cyclin-dependent kinase 2-interacting protein,modified residue,sequence conflict,sequence variant,
80013	family with sequence similarity 188 member A(FAM188A)	Homo sapiens				GO:0006915~apoptotic process,GO:0071108~protein K48-linked deubiquitination,	GO:0005654~nucleoplasm,GO:0031965~nuclear membrane,	GO:0005515~protein binding,GO:0016807~cysteine-type carboxypeptidase activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:1990380~Lys48-specific deubiquitinase activity,	IPR011992:EF-hand-like domain,IPR025257:Domain of unknown function DUF4205,				SM01174:SM01174,	Alternative splicing,Apoptosis,Complete proteome,Hydrolase,Nucleus,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Protein FAM188A,modified residue,sequence conflict,splice variant,
57082	kinetochore scaffold 1(KNL1)	Homo sapiens				GO:0001675~acrosome assembly,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0010923~negative regulation of phosphatase activity,GO:0034080~CENP-A containing nucleosome assembly,GO:0034501~protein localization to kinetochore,GO:0051301~cell division,GO:0071173~spindle assembly checkpoint,	GO:0000777~condensed chromosome kinetochore,GO:0001669~acrosomal vesicle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005515~protein binding,			604321~Microcephaly 4, primary, autosomal recessive,			3D-structure,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosomal rearrangement,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Disease mutation,Kinetochore,Mental retardation,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Primary microcephaly,Proteomics identification,Reference proteome,Repeat,	chain:Protein CASC5,modified residue,region of interest:2 X 104 AA approximate repeats,region of interest:Interaction with BUB1 and BUB1B,region of interest:Necessary for kinetochore localization and for interaction with NSL1 and DSN1,repeat:1,repeat:2,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form MLL- CASC5,splice variant,
9223	membrane associated guanylate kinase, WW and PDZ domain containing 1(MAGI1)	Homo sapiens				GO:0006461~protein complex assembly,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0070997~neuron death,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005923~bicellular tight junction,GO:0030054~cell junction,GO:0042995~cell projection,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0032947~protein complex scaffold,GO:0051393~alpha-actinin binding,	IPR001202:WW domain,IPR001478:PDZ domain,IPR008144:Guanylate kinase,IPR008145:Guanylate kinase/L-type calcium channel,IPR014710:RmlC-like jelly roll fold,IPR020590:Guanylate kinase, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04530:Tight junction,			SM00072:GuKc,SM00228:PDZ,SM00456:WW,	3D-structure,Alternative splicing,ATP-binding,Cell junction,Cell membrane,Coiled coil,Complete proteome,Membrane,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Tight junction,	chain:Connector enhancer of kinase suppressor of ras 3,chain:Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,domain:CRIC,domain:DUF1170,domain:Guanylate kinase-like,domain:PDZ,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,domain:PDZ 4,domain:PDZ 5,domain:PDZ 6,domain:SAM,domain:WW 1,domain:WW 2,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with FCHSD2,sequence conflict,splice variant,strand,turn,
64979	mitochondrial ribosomal protein L36(MRPL36)	Homo sapiens				GO:0006412~translation,GO:0042254~ribosome biogenesis,GO:0070125~mitochondrial translational elongation,GO:0070126~mitochondrial translational termination,	GO:0005743~mitochondrial inner membrane,GO:0005762~mitochondrial large ribosomal subunit,	GO:0003735~structural constituent of ribosome,	IPR000473:Ribosomal protein L36,	hsa03010:Ribosome,				3D-structure,Complete proteome,Mitochondrion,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transit peptide,	chain:39S ribosomal protein L36, mitochondrial,sequence conflict,transit peptide:Mitochondrion,
26469	protein tyrosine phosphatase, non-receptor type 18(PTPN18)	Homo sapiens				GO:0006470~protein dephosphorylation,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR016130:Protein-tyrosine phosphatase, active site,				SM00194:PTPc,SM00404:PTPc_motif,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,	active site:Phosphocysteine intermediate,chain:Tyrosine-protein phosphatase non-receptor type 18,domain:Tyrosine-protein phosphatase,helix,modified residue,sequence conflict,sequence variant,strand,turn,
6045	ring finger protein 2(RNF2)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0001702~gastrulation with mouth forming second,GO:0006351~transcription, DNA-templated,GO:0007281~germ cell development,GO:0009948~anterior/posterior axis specification,GO:0016925~protein sumoylation,GO:0035518~histone H2A monoubiquitination,GO:0036353~histone H2A-K119 monoubiquitination,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,	GO:0000151~ubiquitin ligase complex,GO:0000791~euchromatin,GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,GO:0071339~MLL1 complex,	GO:0003682~chromatin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,GO:0071535~RING-like zinc finger domain binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,	3D-structure,Acetylation,Alternative splicing,Chromosome,Complete proteome,Isopeptide bond,Ligase,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase RING2,helix,modified residue,mutagenesis site,region of interest:Interaction with HIP2,strand,turn,zinc finger region:RING-type,
123016	tetratricopeptide repeat domain 8(TTC8)	Homo sapiens				GO:0001736~establishment of planar polarity,GO:0007411~axon guidance,GO:0007608~sensory perception of smell,GO:0015031~protein transport,GO:0021772~olfactory bulb development,GO:0032880~regulation of protein localization,GO:0034260~negative regulation of GTPase activity,GO:0035264~multicellular organism growth,GO:0042384~cilium assembly,GO:0045444~fat cell differentiation,GO:0048560~establishment of anatomical structure orientation,GO:0050893~sensory processing,GO:0051492~regulation of stress fiber assembly,GO:0060122~inner ear receptor stereocilium organization,GO:0060219~camera-type eye photoreceptor cell differentiation,GO:0060271~cilium morphogenesis,GO:0061326~renal tubule development,GO:0090002~establishment of protein localization to plasma membrane,GO:1903251~multi-ciliated epithelial cell differentiation,	GO:0005813~centrosome,GO:0005829~cytosol,GO:0005929~cilium,GO:0016020~membrane,GO:0032391~photoreceptor connecting cilium,GO:0034464~BBSome,GO:0036064~ciliary basal body,GO:0060170~ciliary membrane,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,		613464~Retinitis pigmentosa 51,615985~Bardet-Biedl syndrome 8,		SM00028:TPR,	Alternative splicing,Bardet-Biedl syndrome,Cell membrane,Cell projection,Ciliopathy,Cilium,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Membrane,Mental retardation,Obesity,Protein transport,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,TPR repeat,Transport,	chain:Tetratricopeptide repeat protein 8,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence variant,splice variant,
51364, 51364, 51364	zinc finger MYND-type containing 10(ZMYND10)	Homo sapiens				GO:0036158~outer dynein arm assembly,GO:0036159~inner dynein arm assembly,GO:0044458~motile cilium assembly,	GO:0005737~cytoplasm,GO:0034451~centriolar satellite,	GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR002893:Zinc finger, MYND-type,IPR017333:Uncharacterised conserved protein UCP037948, zinc finger MYND-type,		615444~Ciliary dyskinesia, primary, 22,	PIRSF037948:uncharacterized protein with zinc finger MYND domain, BLu protein type,		3D-structure,Alternative splicing,Ciliopathy,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Metal-binding,Polymorphism,Primary ciliary dyskinesia,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Zinc finger MYND domain-containing protein 10,helix,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:MYND-type,
151126, 151126, 151126, 151126, 151126	zinc finger protein 385B(ZNF385B)	Homo sapiens				GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0005634~nucleus,	GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,	IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,	Alternative splicing,Apoptosis,Complete proteome,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Zinc finger protein 385B,sequence conflict,sequence variant,splice variant,zinc finger region:Matrin-type 1,zinc finger region:Matrin-type 2,zinc finger region:Matrin-type 3,zinc finger region:Matrin-type 4,
UP_KEYWORDS	Phosphoprotein	48	82.75862068965517	6.04159324261426E-11	988, 215, 863, 84126, 100526767, 26469, 867, 9575, 22995, 51550, 846, 57805, 119, 9223, 7965, 1050, 79959, 5825, 6045, 55835, 367, 55814, 55664, 65057, 22809, 84079, 22897, 57379, 81620, 672, 79577, 55755, 6310, 1111, 9255, 9236, 9738, 23624, 23621, 274, 57082, 8314, 79058, 468, 23607, 80013, 83990, 51411	58	8246	20581	2.065553204479497	9.304047754454814E-9	4.652023877227407E-9	7.247495936724135E-8
UP_KEYWORDS	Coiled coil	29	50.0	8.798649738510929E-10	988, 863, 84126, 100526767, 9575, 22995, 51550, 27063, 57805, 9223, 119, 55835, 367, 80184, 55814, 55664, 22809, 22897, 672, 55755, 9255, 9236, 9738, 274, 57082, 8314, 468, 23607, 51411	58	3036	20581	3.3894927536231885	1.3549919453126336E-7	4.516640017548923E-8	1.0554867979628568E-6
GOTERM_MF_DIRECT	GO:0005515~protein binding	51	87.93103448275862	1.1285781860269274E-8	988, 26469, 846, 27063, 948, 1050, 79959, 8837, 80184, 65057, 84079, 81620, 672, 582, 6310, 55755, 9255, 51364, 9738, 274, 8314, 79058, 23607, 123016, 215, 863, 84126, 867, 9575, 22995, 51550, 57805, 9223, 7965, 5825, 55835, 6045, 367, 55664, 22809, 22897, 57379, 79577, 1111, 9236, 23621, 57082, 468, 80013, 83990, 51411	58	8785	16881	1.6896571350067708	1.8621522843709215E-6	1.8621522843709215E-6	1.369904834014335E-5
UP_KEYWORDS	Isopeptide bond	17	29.310344827586203	4.310720244091847E-8	988, 863, 672, 79577, 6310, 1111, 84126, 100526767, 9255, 9575, 57805, 948, 1050, 6045, 468, 367, 23607	58	1132	20581	5.3289417570366755	6.638487289212236E-6	1.6596259538870228E-6	5.1711426807266037E-5
UP_KEYWORDS	Cytoplasm	33	56.896551724137936	1.0219380881076709E-7	988, 100526767, 26469, 867, 9575, 22995, 57805, 119, 7965, 79959, 55835, 367, 80184, 55664, 22809, 22897, 57379, 672, 582, 1111, 6310, 55755, 9255, 51364, 290, 9738, 274, 8314, 79058, 468, 23607, 51411, 123016	58	4816	20581	2.4314533451712683	1.573772352925218E-5	3.147564520133983E-6	1.2259171663364654E-4
GOTERM_BP_DIRECT	GO:0000086~G2/M transition of mitotic cell cycle	8	13.793103448275861	3.881595781646576E-7	79959, 55835, 80184, 1111, 55755, 22995, 9738, 22897	58	137	16792	16.906116284923232	2.1462925222037743E-4	2.1462925222037743E-4	5.668786586920938E-4
GOTERM_CC_DIRECT	GO:0005813~centrosome	11	18.96551724137931	7.094013154724573E-7	79959, 55835, 582, 80184, 1111, 55755, 22809, 22995, 9738, 123016, 22897	58	426	18224	8.1133236198802	1.1562577026158483E-4	1.1562577026158483E-4	8.5930764760489E-4
GOTERM_CC_DIRECT	GO:0005654~nucleoplasm	25	43.103448275862064	1.0271810432407905E-6	988, 863, 84126, 22995, 9575, 27063, 57805, 9223, 6045, 367, 55814, 65057, 22809, 22897, 81620, 672, 79577, 1111, 6310, 57082, 79058, 8314, 468, 80013, 83990	58	2784	18224	2.8215418152992466	1.6741658031604878E-4	8.371179399024875E-5	0.0012442364400677697
UP_KEYWORDS	Cell cycle	12	20.689655172413794	1.4102299987689361E-6	57082, 988, 81620, 672, 79577, 1111, 23607, 100526767, 9236, 51550, 57805, 22897	58	650	20581	6.550981432360743	2.1715199203786728E-4	3.619527375953169E-5	0.0016917000651428538
UP_KEYWORDS	Cytoskeleton	15	25.862068965517242	1.8948008305743198E-6	582, 1111, 55755, 22995, 9738, 51364, 119, 79959, 55835, 468, 80184, 23607, 22809, 123016, 22897	58	1138	20581	4.677216532331374	2.91757034995177E-4	4.1684788930629324E-5	0.002272981110518213
UP_KEYWORDS	Disease mutation	22	37.93103448275862	2.03679729083918E-6	57379, 81620, 215, 582, 672, 79577, 867, 22995, 51364, 846, 27063, 274, 948, 1050, 57082, 55835, 367, 80184, 65057, 83990, 123016, 22897	58	2550	20581	3.0614063556457065	3.136179138432116E-4	3.920761913944748E-5	0.0024433165106252375
UP_KEYWORDS	Nucleus	32	55.172413793103445	3.0262803697911317E-6	988, 863, 84126, 26469, 9575, 51550, 27063, 57805, 7965, 1050, 6045, 367, 80184, 55814, 65057, 22809, 22897, 57379, 81620, 672, 79577, 1111, 6310, 9255, 274, 57082, 8314, 79058, 468, 80013, 83990, 151126	58	5244	20581	2.1653383834398587	4.6593929869154227E-4	5.1781757293700714E-5	0.0036302682653421847
UP_KEYWORDS	DNA damage	9	15.517241379310345	5.38314771934165E-6	988, 672, 1111, 84126, 9575, 51550, 83990, 57805, 22897	58	352	20581	9.072737068965518	8.286634487673084E-4	8.28972618438506E-5	0.006457437751461459
UP_SEQ_FEATURE	mutagenesis site	19	32.758620689655174	1.6256141180874698E-5	988, 81620, 863, 672, 1111, 84126, 867, 9575, 290, 57805, 7965, 5825, 6045, 8314, 8837, 55814, 367, 83990, 22897	57	2191	20063	3.0523353111212534	0.0042986466834031845	0.0042986466834031845	0.02130968396909516
GOTERM_BP_DIRECT	GO:0007099~centriole replication	4	6.896551724137931	2.0125997161552333E-5	55835, 55755, 22995, 9738	58	16	16792	72.37931034482759	0.011068081475105407	0.005549438873457824	0.029388600143154253
UP_KEYWORDS	Primary microcephaly	4	6.896551724137931	2.2205480616604293E-5	57082, 55835, 55755, 22995	58	20	20581	70.96896551724137	0.0034138415298997637	3.1083186203106905E-4	0.026634462779373536
UP_SEQ_FEATURE	sequence variant	50	86.20689655172413	2.260534417965009E-5	988, 26469, 846, 27063, 948, 119, 8837, 55814, 80184, 65057, 84079, 81620, 672, 582, 6310, 55755, 9255, 51364, 9738, 274, 8314, 79058, 23607, 151126, 123016, 215, 863, 84126, 867, 22995, 9575, 51550, 7965, 5825, 55835, 367, 55664, 22809, 22897, 57379, 79577, 1111, 9236, 290, 23624, 23621, 57082, 468, 83990, 51411	57	12443	20063	1.414379394600783	0.0059725767429466	0.0029907606962443767	0.02963152305421879
GOTERM_CC_DIRECT	GO:0005829~cytosol	25	43.103448275862064	2.3277241746110662E-5	215, 100526767, 867, 22995, 27063, 7965, 119, 5825, 79959, 55835, 8837, 367, 80184, 84079, 22897, 81620, 582, 1111, 55755, 9255, 9738, 290, 57082, 79058, 123016	58	3315	18224	2.3695844385499556	0.0037870455516211265	0.0012639454021111662	0.028192510090385703
GOTERM_CC_DIRECT	GO:0005814~centriole	6	10.344827586206897	2.7152889944702313E-5	79959, 55835, 80184, 22995, 9738, 22897	58	113	18224	16.683552029295086	0.004416200930120295	0.0011058833474001384	0.03288583962159919
UP_KEYWORDS	Cilium biogenesis/degradation	6	10.344827586206897	5.5681933846451534E-5	582, 80184, 22995, 9738, 123016, 22897	58	148	20581	14.385601118359737	0.008538593917509107	7.143494440275955E-4	0.06677565305872601
UP_KEYWORDS	Activator	10	17.24137931034483	7.805046712016683E-5	1050, 988, 672, 468, 55814, 80184, 367, 22809, 9575, 57805	58	661	20581	5.3683029892013145	0.011948286530106045	9.242065835675106E-4	0.09358924295608251
GOTERM_MF_DIRECT	GO:0044212~transcription regulatory region DNA binding	7	12.068965517241379	7.98219083151502E-5	1050, 988, 672, 468, 367, 55755, 22809	58	213	16881	9.565080135988344	0.01308478064865648	0.006563932932096783	0.0968473690660665
GOTERM_BP_DIRECT	GO:0000077~DNA damage checkpoint	4	6.896551724137931	1.4107288682269818E-4	1111, 84126, 9575, 83990	58	30	16792	38.60229885057471	0.07505297160706181	0.02567101935948901	0.20582958516549565
UP_KEYWORDS	DNA repair	7	12.068965517241379	1.5601796637792592E-4	988, 672, 1111, 84126, 51550, 83990, 22897	58	293	20581	8.477521478168766	0.02374225195387858	0.0017148594682654394	0.18699883407141682
UP_KEYWORDS	Mental retardation	7	12.068965517241379	1.7414638016756564E-4	57082, 55835, 582, 80184, 55755, 22995, 123016	58	299	20581	8.307403990312537	0.026464392440613826	0.0017864609085652683	0.20870625234973295
GOTERM_BP_DIRECT	GO:0006260~DNA replication	6	10.344827586206897	1.7863561835239307E-4	81620, 672, 1111, 84126, 51550, 83990	58	155	16792	11.207119021134593	0.09407098083785725	0.024396066066157407	0.2605681717328445
GOTERM_CC_DIRECT	GO:0005737~cytoplasm	30	51.724137931034484	3.27866988078854E-4	988, 215, 26469, 867, 9575, 27063, 57805, 9223, 8837, 367, 80184, 55814, 55664, 65057, 22809, 84079, 57379, 672, 79577, 6310, 55755, 9255, 51364, 274, 57082, 8314, 468, 23607, 83990, 51411	58	5222	18224	1.8050951544526475	0.052047688159742256	0.010633279099698356	0.39642865264564175
GOTERM_BP_DIRECT	GO:0008285~negative regulation of cell proliferation	8	13.793103448275861	3.682741658071569E-4	1050, 8314, 863, 79577, 367, 22809, 83990, 7965	58	396	16792	5.848833159177986	0.18428734413355208	0.03991996162690403	0.5364936544139276
GOTERM_MF_DIRECT	GO:0015631~tubulin binding	4	6.896551724137931	3.8163408796174867E-4	55835, 672, 55755, 22809	58	42	16881	27.719211822660096	0.061039290201342467	0.020775043652717762	0.46225657890007765
UP_KEYWORDS	Ciliopathy	5	8.620689655172415	4.1162618857321694E-4	582, 80184, 51364, 123016, 22897	58	126	20581	14.081143951833608	0.061435297811743506	0.003954876495300685	0.4926711784157489
GOTERM_BP_DIRECT	GO:0007049~cell cycle	6	10.344827586206897	8.346487672052272E-4	672, 79577, 100526767, 9236, 51550, 57805	58	217	16792	8.005085015096139	0.36982233793552133	0.074072106364929	1.212050414801713
UP_KEYWORDS	Bardet-Biedl syndrome	3	5.172413793103448	0.0018366976748731638	582, 80184, 123016	58	23	20581	46.284107946026985	0.24656423751376655	0.016515713723920022	2.1811904491629397
UP_KEYWORDS	Polymorphism	45	77.58620689655173	0.002440179900991427	988, 863, 84126, 26469, 867, 9575, 22995, 51550, 846, 119, 948, 7965, 5825, 55835, 8837, 367, 80184, 55814, 55664, 65057, 22809, 84079, 22897, 57379, 81620, 582, 672, 55755, 1111, 6310, 9255, 9236, 51364, 290, 9738, 23624, 23621, 57082, 8314, 79058, 468, 23607, 83990, 151126, 51411	58	12043	20581	1.3259169012189083	0.3135672002700406	0.0206856628450508	2.888287349826202
UP_KEYWORDS	Alternative splicing	41	70.6896551724138	0.0031107325083403366	863, 84126, 100526767, 26469, 22995, 51550, 846, 57805, 119, 9223, 948, 79959, 5825, 6045, 55835, 8837, 367, 80184, 55814, 65057, 22897, 57379, 582, 672, 55755, 1111, 6310, 9255, 9236, 51364, 9738, 23624, 23621, 274, 57082, 79058, 80013, 83990, 151126, 51411, 123016	58	10587	20581	1.374198349960752	0.38109250349143664	0.02493642310232569	3.6684729028640173
GOTERM_CC_DIRECT	GO:0036064~ciliary basal body	4	6.896551724137931	0.003575550537383017	55835, 582, 80184, 123016	58	98	18224	12.824771287825476	0.4422582122809422	0.09272516707699086	4.2461094147911655
UP_KEYWORDS	Apoptosis	7	12.068965517241379	0.003575611851190956	8837, 100526767, 9255, 80013, 151126, 57805, 7965	58	536	20581	4.634167524446732	0.42399044107335093	0.02720465326387711	4.2059814563469295
GOTERM_CC_DIRECT	GO:0005634~nucleus	28	48.275862068965516	0.003657435393289907	988, 863, 26469, 867, 9575, 51550, 57805, 27063, 7965, 1050, 6045, 367, 80184, 65057, 22809, 57379, 81620, 672, 79577, 1111, 6310, 9255, 23624, 57082, 8314, 468, 83990, 151126	58	5415	18224	1.624707867672812	0.4496797220064429	0.08178353999548915	4.341383708566838
GOTERM_CC_DIRECT	GO:0045121~membrane raft	5	8.620689655172415	0.003923621778037572	8837, 867, 23624, 23621, 948	58	206	18224	7.6263809842651495	0.47313362384096447	0.07697692037711579	4.650495115102693
UP_KEYWORDS	Cell division	6	10.344827586206897	0.004351201636945886	57082, 79577, 23607, 100526767, 51550, 22897	58	388	20581	5.487291148240312	0.4890824910434237	0.03147253173230957	5.096627598021975
INTERPRO	IPR005283:Peroxysomal long chain fatty acyl transporter	2	3.4482758620689653	0.005381107897140308	5825, 215	51	2	18559	363.9019607843137	0.5014429878939428	0.5014429878939428	6.082028981251286
GOTERM_BP_DIRECT	GO:0051301~cell division	6	10.344827586206897	0.006595161421101513	57082, 55835, 79577, 23607, 51550, 22897	58	350	16792	4.963152709359607	0.9742469984616303	0.40710824939964296	9.211429113592285
GOTERM_BP_DIRECT	GO:0071222~cellular response to lipopolysaccharide	4	6.896551724137931	0.006668474494359644	57379, 79577, 27063, 948	58	113	16792	10.24839792493134	0.9752768910226676	0.37029392168985753	9.309231461133827
GOTERM_BP_DIRECT	GO:0045892~negative regulation of transcription, DNA-templated	7	12.068965517241379	0.006728818073927112	1050, 672, 863, 6310, 22809, 9575, 57805	58	499	16792	4.061364107525396	0.9760936682275824	0.3395578669697491	9.38965837934469
GOTERM_BP_DIRECT	GO:0015910~peroxisomal long-chain fatty acid import	2	3.4482758620689653	0.0067776261411196465	5825, 215	58	2	16792	289.51724137931035	0.9767345605080898	0.313451652594567	9.454661967845135
GOTERM_BP_DIRECT	GO:0045893~positive regulation of transcription, DNA-templated	7	12.068965517241379	0.007808753952414024	672, 468, 80184, 367, 55755, 22809, 9575	58	515	16792	3.9351858051556747	0.9869006054060291	0.325718847548652	10.81782788690705
INTERPRO	IPR014741:Adaptor protein Cbl, EF hand-like	2	3.4482758620689653	0.00806101006884595	867, 23624	51	3	18559	242.60130718954247	0.6479859403387188	0.40669227237353367	8.983118855373496
INTERPRO	IPR003153:Adaptor protein Cbl, N-terminal helical	2	3.4482758620689653	0.00806101006884595	867, 23624	51	3	18559	242.60130718954247	0.6479859403387188	0.40669227237353367	8.983118855373496
INTERPRO	IPR003005:Amphiphysin	2	3.4482758620689653	0.00806101006884595	51411, 274	51	3	18559	242.60130718954247	0.6479859403387188	0.40669227237353367	8.983118855373496
INTERPRO	IPR024159:Adaptor protein Cbl, PTB domain	2	3.4482758620689653	0.00806101006884595	867, 23624	51	3	18559	242.60130718954247	0.6479859403387188	0.40669227237353367	8.983118855373496
INTERPRO	IPR014742:Adaptor protein Cbl, SH2-like	2	3.4482758620689653	0.00806101006884595	867, 23624	51	3	18559	242.60130718954247	0.6479859403387188	0.40669227237353367	8.983118855373496
INTERPRO	IPR024162:Adaptor protein Cbl	2	3.4482758620689653	0.00806101006884595	867, 23624	51	3	18559	242.60130718954247	0.6479859403387188	0.40669227237353367	8.983118855373496
UP_SEQ_FEATURE	splice variant	32	55.172413793103445	0.008257509749861162	863, 84126, 22995, 846, 57805, 7965, 9223, 119, 79959, 5825, 8837, 367, 80184, 55814, 65057, 22897, 672, 582, 55755, 9236, 51364, 9738, 23624, 23621, 274, 57082, 79058, 80013, 83990, 151126, 51411, 123016	57	7760	20063	1.4514740459395912	0.8889000282728757	0.5192662095395506	10.300526945746913
GOTERM_BP_DIRECT	GO:0006281~DNA repair	5	8.620689655172415	0.008271824785349501	988, 672, 1111, 51550, 22897	58	235	16792	6.159941305942773	0.9898810266774885	0.318036123273285	11.423772324349713
UP_SEQ_FEATURE	domain:CBL N-terminal	2	3.4482758620689653	0.008350687386177868	867, 23624	57	3	20063	234.6549707602339	0.8916321339795057	0.4262467873379946	10.410949529672209
UP_SEQ_FEATURE	domain:EF-hand-like 1	2	3.4482758620689653	0.008350687386177868	867, 23624	57	3	20063	234.6549707602339	0.8916321339795057	0.4262467873379946	10.410949529672209
UP_SEQ_FEATURE	binding site:Phosphotyrosine	2	3.4482758620689653	0.008350687386177868	867, 23624	57	3	20063	234.6549707602339	0.8916321339795057	0.4262467873379946	10.410949529672209
UP_SEQ_FEATURE	domain:EF-hand-like 2	2	3.4482758620689653	0.008350687386177868	867, 23624	57	3	20063	234.6549707602339	0.8916321339795057	0.4262467873379946	10.410949529672209
UP_SEQ_FEATURE	region of interest:4H	2	3.4482758620689653	0.008350687386177868	867, 23624	57	3	20063	234.6549707602339	0.8916321339795057	0.4262467873379946	10.410949529672209
GOTERM_BP_DIRECT	GO:1901796~regulation of signal transduction by p53 class mediator	4	6.896551724137931	0.008604304868048149	672, 1111, 84126, 83990	58	124	16792	9.339265850945495	0.9915936608390846	0.30760427539127677	11.856466441872271
GOTERM_BP_DIRECT	GO:0042384~cilium assembly	4	6.896551724137931	0.008604304868048149	582, 80184, 123016, 22897	58	124	16792	9.339265850945495	0.9915936608390846	0.30760427539127677	11.856466441872271
INTERPRO	IPR004827:Basic-leucine zipper domain	3	5.172413793103448	0.009309359599547332	1050, 468, 22809	51	54	18559	20.21677559912854	0.700766826079147	0.3311379128577455	10.306334029690822
UP_SEQ_FEATURE	compositionally biased region:Poly-Gln	4	6.896551724137931	0.009458397330210902	367, 6310, 9575, 9223	57	156	20063	9.02519118308592	0.9194118925448124	0.3956977776786522	11.714086206590157
UP_KEYWORDS	Obesity	3	5.172413793103448	0.01018663589730797	582, 80184, 123016	58	55	20581	19.355172413793102	0.7933619793696722	0.06916395461717917	11.558213838446163
INTERPRO	IPR017907:Zinc finger, RING-type, conserved site	4	6.896551724137931	0.010628943200823918	6045, 672, 867, 23624	51	169	18559	8.613064160575473	0.748036885538002	0.2915091562336697	11.6859192249388
UP_SEQ_FEATURE	DNA-binding region:Basic motif	4	6.896551724137931	0.010652024314517753	1050, 468, 22809, 9575	57	163	20063	8.637606285652783	0.9414531658687777	0.3768624783854826	13.098683280267798
GOTERM_MF_DIRECT	GO:0001085~RNA polymerase II transcription factor binding	3	5.172413793103448	0.010985832480210933	468, 367, 27063	58	47	16881	18.577769625825383	0.8384099473899241	0.3659789813217704	12.54864553434194
GOTERM_BP_DIRECT	GO:0060271~cilium morphogenesis	4	6.896551724137931	0.01105638111207105	582, 80184, 123016, 22897	58	136	16792	8.51521298174442	0.9978627393163204	0.3554219155606536	14.987344929127778
UP_SEQ_FEATURE	region of interest:Interaction with BRCA1	2	3.4482758620689653	0.011119000522029873	8314, 83990	57	4	20063	175.99122807017542	0.948338313813764	0.34511214028015225	13.634891572549613
SMART	SM00338:BRLZ	3	5.172413793103448	0.011348500422187074	1050, 468, 22809	33	51	10057	17.92691622103387	0.3369347629164129	0.3369347629164129	9.678908985768143
UP_KEYWORDS	Tumor suppressor	4	6.896551724137931	0.01302698163016868	672, 79577, 57805, 274	58	177	20581	8.019092148840834	0.867256534978217	0.08405343782925201	14.555111041977199
KEGG_PATHWAY	hsa03460:Fanconi anemia pathway	3	5.172413793103448	0.013174686431022674	672, 84126, 83990	24	53	6910	16.297169811320757	0.5887566906287538	0.5887566906287538	12.717623614672425
UP_SEQ_FEATURE	short sequence motif:Nuclear localization signal	5	8.620689655172415	0.015499303050244044	57082, 79577, 6310, 83990, 23624	57	344	20063	5.116024071807425	0.9840688400118321	0.4039524257194629	18.51790110401633
UP_SEQ_FEATURE	domain:SH2; atypical	2	3.4482758620689653	0.016632875821232428	867, 23624	57	6	20063	117.32748538011695	0.9882603134448593	0.389736509016	19.739341865889504
GOTERM_BP_DIRECT	GO:0006357~regulation of transcription from RNA polymerase II promoter	6	10.344827586206897	0.016706101130696746	988, 672, 468, 22809, 9575, 83990	58	441	16792	3.939010086793338	0.9999100731276006	0.46264746840869375	21.811061337958915
GOTERM_MF_DIRECT	GO:0005324~long-chain fatty acid transporter activity	2	3.4482758620689653	0.01677123136536941	5825, 215	58	5	16881	116.42068965517241	0.938623058325774	0.42772990868007466	18.559793017780457
GOTERM_BP_DIRECT	GO:0045944~positive regulation of transcription from RNA polymerase II promoter	9	15.517241379310345	0.017114764571803456	1050, 672, 468, 79577, 367, 9236, 22809, 9575, 27063	58	981	16792	2.6561214805441318	0.9999285413768737	0.4493464857188192	22.284301241899318
UP_SEQ_FEATURE	region of interest:Interaction with PEX19	2	3.4482758620689653	0.01937847880122234	5825, 215	57	7	20063	100.56641604010025	0.9944040172486286	0.40462905484040523	22.62801810585533
UP_KEYWORDS	Cilium	4	6.896551724137931	0.019711933588404305	582, 80184, 9738, 123016	58	207	20581	6.856904880892887	0.9533907378830556	0.1199250165334862	21.24482586311861
GOTERM_BP_DIRECT	GO:0046599~regulation of centriole replication	2	3.4482758620689653	0.020197766611244804	79959, 55835	58	6	16792	96.50574712643679	0.9999874238108504	0.4850818739607813	25.76942217606707
GOTERM_BP_DIRECT	GO:0046600~negative regulation of centriole replication	2	3.4482758620689653	0.020197766611244804	672, 55755	58	6	16792	96.50574712643679	0.9999874238108504	0.4850818739607813	25.76942217606707
GOTERM_BP_DIRECT	GO:0042760~very long-chain fatty acid catabolic process	2	3.4482758620689653	0.020197766611244804	5825, 215	58	6	16792	96.50574712643679	0.9999874238108504	0.4850818739607813	25.76942217606707
GOTERM_MF_DIRECT	GO:0008022~protein C-terminus binding	4	6.896551724137931	0.02357298410954102	468, 6310, 23607, 9223	58	182	16881	6.396741189844638	0.9804761771623547	0.4810874873910571	25.14094088912494
UP_KEYWORDS	Transcription regulation	13	22.413793103448278	0.024100951950145652	988, 863, 672, 79577, 6310, 9575, 57805, 1050, 6045, 468, 367, 55814, 22809	58	2332	20581	1.9781229668184774	0.97664640565386	0.13953313859357086	25.372135040314138
GOTERM_BP_DIRECT	GO:0045444~fat cell differentiation	3	5.172413793103448	0.02550629062001381	1050, 22809, 123016	58	73	16792	11.897968823807275	0.9999993765392668	0.5478659939596999	31.431340760236136
GOTERM_MF_DIRECT	GO:0019899~enzyme binding	5	8.620689655172415	0.025911241108092675	215, 672, 367, 57805, 23621	58	333	16881	4.370146008077043	0.9868550872568549	0.46141890980755673	27.288137904453503
UP_SEQ_FEATURE	zinc finger region:RING-type	4	6.896551724137931	0.02641235206688083	6045, 672, 867, 23624	57	230	20063	6.121434019832188	0.9991694043501721	0.4752595857149081	29.596035645885234
KEGG_PATHWAY	hsa05100:Bacterial invasion of epithelial cells	3	5.172413793103448	0.027304315549998806	23607, 867, 23624	24	78	6910	11.073717948717949	0.843520205783676	0.6044247300243303	24.718490257575176
UP_SEQ_FEATURE	region of interest:Self-association	2	3.4482758620689653	0.027570192821135122	6310, 55664	57	10	20063	70.39649122807018	0.9993940461365316	0.46065089396088577	30.685839617323076
GOTERM_CC_DIRECT	GO:0034464~BBSome	2	3.4482758620689653	0.027806098375008224	582, 123016	58	9	18224	69.82375478927203	0.9899139416000466	0.3999447008685503	28.936187312699246
UP_KEYWORDS	Transcription	13	22.413793103448278	0.0292519712381453	988, 863, 672, 79577, 6310, 9575, 57805, 1050, 6045, 468, 367, 55814, 22809	58	2398	20581	1.9236792154381523	0.9896627821725472	0.16125313423890952	29.962656468297798
GOTERM_BP_DIRECT	GO:0035264~multicellular organism growth	3	5.172413793103448	0.030211938094764742	367, 22809, 123016	58	80	16792	10.856896551724137	0.9999999571166203	0.5905265598701166	36.111249955225745
GOTERM_BP_DIRECT	GO:0006974~cellular response to DNA damage stimulus	4	6.896551724137931	0.03361978044300784	672, 1111, 867, 57805	58	208	16792	5.567639257294429	0.9999999938784461	0.6115428817910605	39.31277171441441
GOTERM_BP_DIRECT	GO:0070997~neuron death	2	3.4482758620689653	0.03672263523152984	867, 9223	58	11	16792	52.63949843260188	0.9999999989660502	0.626647535314057	42.097167637535236
GOTERM_BP_DIRECT	GO:0030851~granulocyte differentiation	2	3.4482758620689653	0.03672263523152984	1050, 863	58	11	16792	52.63949843260188	0.9999999989660502	0.626647535314057	42.097167637535236
GOTERM_BP_DIRECT	GO:0045945~positive regulation of transcription from RNA polymerase III promoter	2	3.4482758620689653	0.03672263523152984	1050, 367	58	11	16792	52.63949843260188	0.9999999989660502	0.626647535314057	42.097167637535236
GOTERM_BP_DIRECT	GO:0007175~negative regulation of epidermal growth factor-activated receptor activity	2	3.4482758620689653	0.03672263523152984	867, 23624	58	11	16792	52.63949843260188	0.9999999989660502	0.626647535314057	42.097167637535236
UP_SEQ_FEATURE	domain:ABC transmembrane type-1	2	3.4482758620689653	0.038388010094828715	5825, 215	57	14	20063	50.283208020050125	0.9999687416914187	0.5497446492138608	40.14113249723612
INTERPRO	IPR011992:EF-hand-like domain	4	6.896551724137931	0.039239756072549085	867, 80013, 23624, 57805	51	279	18559	5.217232412678333	0.9942807634023757	0.6439855606177741	37.21991877064058
UP_KEYWORDS	Ubl conjugation pathway	6	10.344827586206897	0.039683808411695054	6045, 8314, 672, 867, 80013, 23624	58	680	20581	3.130983772819473	0.9980420810045261	0.20622740513938298	38.47647632644259
UP_SEQ_FEATURE	domain:Leucine-zipper	3	5.172413793103448	0.039753423006624544	1050, 468, 22809	57	113	20063	9.344666977177456	0.9999785496965	0.5359861324543183	41.24588404758895
GOTERM_CC_DIRECT	GO:0043234~protein complex	5	8.620689655172415	0.03978628340867019	79959, 672, 80184, 367, 9738	58	412	18224	3.8131904921325748	0.9986635011049455	0.48406277862961633	38.84680476632264
GOTERM_MF_DIRECT	GO:0043522~leucine zipper domain binding	2	3.4482758620689653	0.039787572984397855	988, 468	58	12	16881	48.50862068965517	0.9987680071795825	0.5671613616714571	38.910183406127516
SMART	SM00184:RING	4	6.896551724137931	0.04172288137694702	6045, 672, 867, 23624	33	244	10057	4.996025832091406	0.7843843595671393	0.535655687627316	31.622361112781427
INTERPRO	IPR004148:BAR domain	2	3.4482758620689653	0.04226237625559746	51411, 274	51	16	18559	45.48774509803921	0.9961910544392136	0.6048146883359451	39.478842294063554
GOTERM_BP_DIRECT	GO:0006915~apoptotic process	6	10.344827586206897	0.04285779613705541	8837, 672, 100526767, 9255, 80013, 7965	58	567	16792	3.063674511950374	0.9999999999698015	0.6674801786989044	47.2558281747974
GOTERM_MF_DIRECT	GO:0001784~phosphotyrosine binding	2	3.4482758620689653	0.043032110796091094	867, 23624	58	13	16881	44.777188328912466	0.9992952009839077	0.55353745339724	41.3691748630046
GOTERM_BP_DIRECT	GO:0006359~regulation of transcription from RNA polymerase III promoter	2	3.4482758620689653	0.04325564153338403	672, 55814	58	13	16792	44.54111405835543	0.9999999999760041	0.6546440993263425	47.57510381764077
UP_SEQ_FEATURE	domain:ABC transporter	2	3.4482758620689653	0.04375250753481882	5825, 215	57	16	20063	43.997807017543856	0.9999929020657533	0.546327837655727	44.37410797445549
GOTERM_CC_DIRECT	GO:0048471~perinuclear region of cytoplasm	6	10.344827586206897	0.044304810754771294	988, 215, 79058, 55755, 23607, 867	58	621	18224	3.035815425620523	0.9993804702311531	0.4890607230959485	42.24292079480709
INTERPRO	IPR001841:Zinc finger, RING-type	4	6.896551724137931	0.045058629474913965	6045, 672, 867, 23624	51	295	18559	4.934263875041542	0.9973878663294281	0.5724377611848667	41.50218358379977
UP_SEQ_FEATURE	domain:BAR	2	3.4482758620689653	0.04642372315780243	51411, 274	57	17	20063	41.40970072239422	0.9999966178637452	0.5449339422738312	46.37713162261521
SMART	SM00721:BAR	2	3.4482758620689653	0.046711223068926645	51411, 274	33	15	10057	40.634343434343435	0.8213178030062884	0.4367596479909849	34.73244874554213
UP_KEYWORDS	Biological rhythms	3	5.172413793103448	0.04702216707114597	468, 9575, 57805	58	125	20581	8.516275862068966	0.9993991708434876	0.23271732365314945	43.885245911667994
UP_KEYWORDS	Cell projection	6	10.344827586206897	0.048912731122773216	582, 80184, 23607, 9738, 51411, 123016	58	721	20581	2.9529389258214165	0.9995574761120787	0.23379912167585715	45.20620995672814
GOTERM_BP_DIRECT	GO:0042692~muscle cell differentiation	2	3.4482758620689653	0.049745112724355355	27063, 274	58	15	16792	38.60229885057471	0.9999999999994433	0.6913976383651057	52.535359442214855
GOTERM_MF_DIRECT	GO:0003677~DNA binding	11	18.96551724137931	0.051955268964737844	1050, 988, 81620, 672, 468, 55814, 367, 6310, 9575, 83990, 27063	58	1674	16881	1.9125262637498455	0.9998497699660116	0.5853557220392123	47.67119869630356
KEGG_PATHWAY	hsa04144:Endocytosis	4	6.896551724137931	0.05250970105210936	100526767, 867, 23624, 274	24	258	6910	4.463824289405684	0.9730530430837425	0.7001965846559987	42.48995689758128
UP_KEYWORDS	Dwarfism	3	5.172413793103448	0.053226600268071904	55835, 81620, 22995	58	134	20581	7.944287184765827	0.9997802689995152	0.24479815127553672	48.11433677611443
GOTERM_BP_DIRECT	GO:0071356~cellular response to tumor necrosis factor	3	5.172413793103448	0.05375532743518514	1050, 672, 27063	58	110	16792	7.895924764890283	0.9999999999999463	0.7054247489220553	55.378210362008275
UP_KEYWORDS	Nephronophthisis	2	3.4482758620689653	0.053981728255502806	80184, 22897	58	20	20581	35.484482758620686	0.9998056758443602	0.2409418323881679	48.60859640345245
GOTERM_CC_DIRECT	GO:0005770~late endosome	3	5.172413793103448	0.055885089754767504	100526767, 84079, 23621	58	122	18224	7.7263990955342	0.9999150718630132	0.5421172317673741	50.17223229190266
INTERPRO	IPR002893:Zinc finger, MYND-type	2	3.4482758620689653	0.05765522550521773	863, 51364	51	22	18559	33.08199643493761	0.9995289493181134	0.6161748267694072	49.87275303861332
GOTERM_CC_DIRECT	GO:0000242~pericentriolar material	2	3.4482758620689653	0.057811313296567655	55755, 22995	58	19	18224	33.07441016333938	0.9999391199107001	0.5260539940149487	51.38980280352256
GOTERM_BP_DIRECT	GO:0006461~protein complex assembly	3	5.172413793103448	0.05904886543744039	23607, 9223, 119	58	116	16792	7.487514863258026	0.9999999999999976	0.7259739079256593	58.88830477395375
GOTERM_BP_DIRECT	GO:0007031~peroxisome organization	2	3.4482758620689653	0.059398314029272814	5825, 215	58	18	16792	32.16858237547893	0.999999999999998	0.7146943188550496	59.11072064841739
UP_SEQ_FEATURE	zinc finger region:MYND-type	2	3.4482758620689653	0.05967026056913889	863, 51364	57	22	20063	31.99840510366826	0.9999999169680056	0.6167474725320167	55.36213955250341
GOTERM_MF_DIRECT	GO:0017124~SH3 domain binding	3	5.172413793103448	0.06119178160667357	23607, 867, 23624	58	119	16881	7.33743842364532	0.9999701334086349	0.6121594251840761	53.53464265726979
GOTERM_BP_DIRECT	GO:0051298~centrosome duplication	2	3.4482758620689653	0.06259458779473137	22995, 9738	58	19	16792	30.475499092558984	0.9999999999999997	0.7210237266515831	61.09369698247376
GOTERM_MF_DIRECT	GO:0016874~ligase activity	4	6.896551724137931	0.0630110803835611	6045, 672, 867, 23624	58	270	16881	4.311877394636015	0.9999783137179821	0.5913525827330637	54.615911147341436
UP_KEYWORDS	Chromosomal rearrangement	4	6.896551724137931	0.06528587203954747	57082, 988, 79058, 863	58	334	20581	4.249638653727028	0.9999694833908036	0.2774103134643511	55.50996949866198
GOTERM_BP_DIRECT	GO:0045664~regulation of neuron differentiation	2	3.4482758620689653	0.06578019016388445	55755, 274	58	20	16792	28.951724137931034	1.0	0.7267913940032249	62.980616323711615
GOTERM_BP_DIRECT	GO:0031572~G2 DNA damage checkpoint	2	3.4482758620689653	0.06578019016388445	672, 1111	58	20	16792	28.951724137931034	1.0	0.7267913940032249	62.980616323711615
GOTERM_BP_DIRECT	GO:0007166~cell surface receptor signaling pathway	4	6.896551724137931	0.06607840018013739	867, 23624, 9223, 948	58	274	16792	4.226529071230808	1.0	0.7163896512992117	63.15281925630667
GOTERM_MF_DIRECT	GO:0000993~RNA polymerase II core binding	2	3.4482758620689653	0.06860357459376734	79577, 57805	58	21	16881	27.719211822660096	0.9999919238658092	0.5942613077206305	57.79680501434504
GOTERM_CC_DIRECT	GO:0031674~I band	2	3.4482758620689653	0.06955697444749605	27063, 274	58	23	18224	27.32233883058471	0.9999921216562202	0.5680239810762461	58.24259245192827
UP_KEYWORDS	Ligase	4	6.896551724137931	0.07144829086516287	6045, 672, 867, 23624	58	347	20581	4.090430289178177	0.9999889810951669	0.2924424480394805	58.903805409194774
UP_SEQ_FEATURE	region of interest:Linker	2	3.4482758620689653	0.07273602569914572	867, 23624	57	27	20063	26.07277452891488	0.9999999979634383	0.6710264538377921	62.84332891238162
GOTERM_BP_DIRECT	GO:0051092~positive regulation of NF-kappaB transcription factor activity	3	5.172413793103448	0.0749569930879869	8837, 367, 9575	58	133	16792	6.530464091262639	1.0	0.7509007658850161	67.95071370977126
KEGG_PATHWAY	hsa04120:Ubiquitin mediated proteolysis	3	5.172413793103448	0.07529731398759791	672, 867, 23624	24	137	6910	6.304744525547445	0.9947259774504534	0.7305144421801191	55.19697588089595
INTERPRO	IPR011527:ABC transporter, transmembrane domain, type 1	2	3.4482758620689653	0.07530728812283909	5825, 215	51	29	18559	25.096686950642326	0.9999589163450293	0.6744408566604667	59.768330421235774
INTERPRO	IPR027267:Arfaptin homology (AH) domain/BAR domain	2	3.4482758620689653	0.07530728812283909	51411, 274	51	29	18559	25.096686950642326	0.9999589163450293	0.6744408566604667	59.768330421235774
GOTERM_CC_DIRECT	GO:0034451~centriolar satellite	2	3.4482758620689653	0.07827169860226575	80184, 51364	58	26	18224	24.16976127320955	0.9999983006752591	0.5875685655208298	62.74122224667673
GOTERM_BP_DIRECT	GO:0071108~protein K48-linked deubiquitination	2	3.4482758620689653	0.07841658386527375	8314, 80013	58	24	16792	24.126436781609197	1.0	0.7561546724980703	69.65737400067493
UP_KEYWORDS	Triplet repeat expansion	2	3.4482758620689653	0.07988844993234512	367, 6310	58	30	20581	23.65632183908046	0.9999972995615175	0.31416656185221215	63.16759309745519
UP_KEYWORDS	Acetylation	15	25.862068965517242	0.08092866159618484	672, 582, 79577, 9255, 51550, 274, 23621, 57805, 119, 1050, 5825, 6045, 79058, 22809, 83990	58	3424	20581	1.5545188124395748	0.9999977312831759	0.31017873245339767	63.66401448221672
GOTERM_BP_DIRECT	GO:0043065~positive regulation of apoptotic process	4	6.896551724137931	0.08172015463282424	468, 57805, 27063, 274	58	300	16792	3.860229885057471	1.0	0.760364234921567	71.20770340330573
GOTERM_CC_DIRECT	GO:0005815~microtubule organizing center	3	5.172413793103448	0.08286601098793739	468, 55755, 22995	58	153	18224	6.160919540229885	0.9999992474340585	0.5857294747391137	64.92954761156145
GOTERM_CC_DIRECT	GO:0000794~condensed nuclear chromosome	2	3.4482758620689653	0.08403691141436989	672, 1111	58	28	18224	22.44334975369458	0.9999993889038115	0.5690002345438068	65.4680757007142
GOTERM_BP_DIRECT	GO:0006997~nucleus organization	2	3.4482758620689653	0.08467165685667401	1111, 274	58	26	16792	22.270557029177716	1.0	0.7628300018585	72.53007877870324
GOTERM_BP_DIRECT	GO:0000732~strand displacement	2	3.4482758620689653	0.08467165685667401	672, 83990	58	26	16792	22.270557029177716	1.0	0.7628300018585	72.53007877870324
GOTERM_MF_DIRECT	GO:0001103~RNA polymerase II repressing transcription factor binding	2	3.4482758620689653	0.08734045872639638	582, 123016	58	27	16881	21.55938697318008	0.9999997175433909	0.6594265108765482	67.02268579214925
GOTERM_BP_DIRECT	GO:0035058~nonmotile primary cilium assembly	2	3.4482758620689653	0.08778353300933106	55835, 582	58	27	16792	21.44572158365262	1.0	0.7658215421877679	73.86288773223089
GOTERM_BP_DIRECT	GO:0010575~positive regulation of vascular endothelial growth factor production	2	3.4482758620689653	0.08778353300933106	672, 468	58	27	16792	21.44572158365262	1.0	0.7658215421877679	73.86288773223089
UP_KEYWORDS	Protein transport	5	8.620689655172415	0.08839084181000825	582, 80184, 100526767, 84079, 123016	58	610	20581	2.9085641605426797	0.9999993535474576	0.32691414724913914	67.04930674378227
UP_KEYWORDS	Host-virus interaction	4	6.896551724137931	0.09088959397046685	1050, 8837, 290, 274	58	385	20581	3.6866995073891626	0.9999995763952221	0.32740180321761503	68.11659425122825
GOTERM_CC_DIRECT	GO:0043231~intracellular membrane-bounded organelle	5	8.620689655172415	0.09672344779033852	5825, 79058, 6310, 1111, 9575	58	558	18224	2.8154739834383884	0.9999999370812505	0.6019549506216879	70.83591537194462
GOTERM_MF_DIRECT	GO:0043565~sequence-specific DNA binding	5	8.620689655172415	0.09727932556867575	988, 468, 367, 22809, 9575	58	518	16881	2.809379576620956	0.9999999536223034	0.6755951949203077	71.12695586459314
GOTERM_MF_DIRECT	GO:0008270~zinc ion binding	8	13.793103448275861	0.09734511134652112	57379, 6045, 672, 367, 867, 290, 151126, 23624	58	1169	16881	1.9917996519276715	0.999999954176647	0.6522093285539614	71.15248603546272
UP_KEYWORDS	Chromosome	4	6.896551724137931	0.09911707318218854	57082, 6045, 672, 65057	58	400	20581	3.548448275862069	0.999999895545564	0.34493024280474527	71.41085326643133
GOTERM_MF_DIRECT	GO:0042803~protein homodimerization activity	6	10.344827586206897	0.09935492258170685	1050, 5825, 215, 100526767, 9255, 119	58	730	16881	2.392205951818611	0.9999999682782494	0.6378375983069093	71.92254250998144
